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Abstract 
There is growing interest in the reuse of clinical data for research and clinical healthcare 
quality improvement. However, direct analysis of clinical data sets can yield misleading 
results. Data Cleaning is often employed as a means to detect and fix data issues during 
analysis but this approach lacks of systematicity. Data Quality (DQ) assessments are a 
more thorough way of spotting threats to the validity of analytical results stemming from 
data repurposing. This is because DQ assessments aim to evaluate ‘fitness for purpose’. 
However, there is currently no systematic method to assess DQ for the secondary analysis 
of clinical data. In this dissertation I present DataGauge, a framework to address this gap 
in the state of the art. 
 I begin by introducing the problem and its general significance to the field of biomedical 
and clinical informatics (Chapter 1). I then present a literature review that surveys current 
methods for the DQ assessment of repurposed clinical data and derive the features 
required to advance the state of the art (Chapter 2). In chapter 3 I present DataGauge, a 
model-driven framework for systematically assessing the quality of repurposed clinical 
data, which addresses current limitations in the state of the art. Chapter 4 describes the 
development of a guidance framework to ensure the systematicity of DQ assessment 
design. I then evaluate DataGauge’s ability to flag potential DQ issues in comparison to a 
systematic state of the art method. DataGauge was able to increase ten fold the number of 
 viii 
 
potential DQ issues found over the systematic state of the art method. It identified more 
specific issues that were a direct threat to fitness for purpose, but also provided broader 
coverage of the clinical data types and knowledge domains involved in secondary 
analyses.  
DataGauge sets the groundwork for systematic and purpose-specific DQ assessments that 
fully integrate with secondary analysis workflows. It also promotes a team-based 
approach and the explicit definition of DQ requirements to support communication and 
transparent reporting of DQ results. Overall, this work provides tools that pave the way to 
a deeper understanding of repurposed clinical dataset limitations before analysis. It is also 
a first step towards the automation of purpose-specific DQ assessments for the secondary 
use of clinical data. Future work will consist of further development of these methods and 
validating them with research teams making secondary use of clinical data.   
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Chapter 1: Introduction 
There is growing interest in the reuse of clinical data for research and clinical healthcare 
quality improvement. However, direct analysis of clinical data sets can yield misleading 
results (Hersh et al., 2013; C. Safran, 2014). Notably, van der Lei formulated the first law 
of informatics (Van Der Lei, 1991): “Data shall be used only for the purpose for which 
they were collected.” On the other hand, clinical data routinely serve multiple purposes 
including clinical, billing, administrative and legal. Data quality (DQ) flaws are often 
cited as one cause of these misleading results (Dentler et al., 2014; Dentler, ten Teije, de 
Keizer, & Cornet, 2013; Weiner & Embi, 2009). Thus, DQ assessment is generally 
recommended to prevent the hazards of data repurposing (Brown, Kahn, & Toh, 2013; 
Hersh, 2007; M. G. Kahn, Raebel, Glanz, Riedlinger, & Steiner, 2012).  
Once data are acquired it is difficult to change their quality (Hogan & Wagner, 1997; Van 
Der Lei, 1991). However, verifying their accuracy and ability to satisfy the needs of their 
intended secondary uses has the potential to increase confidence by unlocking a deeper 
understanding of the dataset's strengths, weaknesses, flaws and limitations. The results of 
secondary analyses can be then be interpreted in the light of this information as an 
indication of their validity. This idea is analogous to the concept of statistical confidence 
interval (Brookmeyer & Crowley, 1982), which has enabled the understanding of many 
complex phenomena with a well-defined degree of certainty.  
  
 
2 
There is currently no generalized method or approach to carry out such evaluation 
systematically for the secondary use of clinical data. However, quality is routinely 
evaluated for products taking into account their intended purpose. To ensure 
systematicity, these evaluations apply quality control standards and methodologies (Dale, 
2015; Evans & Lindsay, 1999; Juran, 1962; Taguchi, 1986; Walker & Gee, 2000) that 
require the explicit definition of quantitative requirements. Model-driven engineering 
(Schmidt, 2006) supports the definition and testing of these requirements for the 
systematic and purpose-driven evaluation of software products. 
In this thesis I propose and evaluate DataGauge, a framework to systematically assess the 
quality of repurposed clinical datasets based on these model-driven software quality 
assessment methods. I define a general process for the assessment of repurposed clinical 
datasets and provide guidance for the development of DQ requirements specifically for 
the secondary use of clinical data. Finally, I evaluate the ability of this framework to 
catch more potential DQ issues than the current state of the art methods of systematic DQ 
assessment for the secondary use of clinical data.  
1.1 - The Reuse of Clinical Data: Availability, Benefits and Limitations  
Unprecedented amounts of data are created every day though the recoding of clinical care 
information in patient records. As a result, clinical enterprises hold large amounts of data. 
For instance, it has been reported that healthcare data storage needs at Beth Israel 
Deaconess Medical Center have increased approximately six orders of magnitude (i.e., 
from gigabytes to petabytes) over the past three decades (C. Safran, 2014). The HITECH 
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act of 2009 has also been a driving force for growth by providing incentives for 
healthcare institutions that successfully adopted interoperability-capable Electronic 
Health Records (EHR) (Blumenthal, 2010). These efforts have been fueled by the 
understanding that health IT can help lower costs and increase the quality of care in 
medical institutions (Jha AK, 2010). The Institute of Medicine's report defining learning 
healthcare systems (Institute of Medicine (US) Roundtable on Evidence-Based Medicine, 
2007) has also stimulated the secondary use of clinical data for evidence-based medicine 
and healthcare quality improvement. 
Benefits from the reuse of this wealth of data have been noted for several decades (Fries 
& McShane, 1979; C. Safran, 1991; Starmer, Rosati, & Fred McNeer, 1974). Providing 
new ways to approach evidence-based medicine, surveillance, clinical research and 
clinical care quality assurance are often cited as the main benefits (Guyatt G, Cairns J, 
Churchill D, & et al, 1992; Hersh, 2007; Charles Safran et al., 2007). Other applications 
include cohort analyses to determine readmission risk (Phillips, Safran, Cleary, & 
Delbanco, 1987); description of patient populations (Hansell, Hollowell, Nichols, 
McNiece, & Strachan, 1999; Herrmann & Safran, 1992); infection control  and 
epidemiological monitoring (C, Kp, & W, 1994; Classen & Burke, 1995; Samore, 
Lichtenberg, Saubermann, Kawachi, & Carmeli, 1997); and discovery of pharmaco-
epidemiological relationships (Brownstein, Sordo, Kohane, & Mandl, 2007; Chalasani, 
Aljadhey, Kesterson, Murray, & Hall, 2004; Herzig SJ, Howell MD, Ngo LH, & 
Marcantonio ER, 2009). An additional benefit is that, like other forms of retrospective 
research, the reuse of clinical data has the potential to yield valuable insights at very low 
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cost and extremely short time. Because they do not require patient recruitment or data 
collection, the research is reduced to the time of data extraction plus analysis. 
However, repurposed clinical data have many limitations (Hersh et al., 2013). Issues such 
as inaccuracy (Hogan & Wagner, 1997), incompleteness (Nicole G. Weiskopf, Rusanov, 
& Weng, 2013), bias (George Hripcsak, Knirsch, Zhou, Wilcox, & Melton, 2011), coding 
standard inconsistencies (George Hripcsak, Knirsch, Zhou, Wilcox, & Melton, 2007), 
inaccessible data (e.g., clinical notes) (George Hripcsak et al., 1995), heterogeneity (De 
Lusignan et al., 2011) and clinical workflow influences on data recording (George 
Hripcsak, Albers, & Perotte, 2011) have been reported in the literature. Dentler et al. 
clearly showed the impact of these issues by attempting clinical quality indicators 
calculations directly from EHR data (Dentler et al., 2014). They found that only three out 
of eight quality indicators could be computed directly from repurposed clinical data due 
to an average record completeness of 50% and average correctness of 87%. These 
limitations have also been reported in the literature for decades. For example, a meta-
analysis of data accuracy assessments on EHR data published in 1997 revealed highly 
variable results (Hogan & Wagner, 1997) (e.g., accuracy measurements varying from 44 
to 100%). These results clearly reveal the limited reliability of repurposed EHR data and 
strongly caution against their direct reuse for purposes other than patient care. Such 
findings motivated van der Lei, in 1991, to formulate the first law of informatics (Van 
Der Lei, 1991): “Data shall be used only for the purpose for which they were collected.” 
By definition, secondary use violates this law, making it is necessary to assess whether 
clinical data are adequate for any intended purpose other than the original. 
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1.2 - Ensuring Analytical Validity Through Data Checking 
Current practices suggest the use of data cleaning methods to ensure reliable results 
(Broeck & Fadnes, 2013). The data cleaning process happens as the analysis is carried 
out and aims to detect faulty data. Data cleaning happens in three steps: (1) Screen for 
anomalous data, (2) Diagnose possible issues and (3) Address the issues found.  The 
screening step consists in detecting a lack or excess of data, screening for outliers, 
inconsistencies, "strange" patterns and suspect analytical results (Van den Broeck, 
Argeseanu Cunningham, Eeckels, & Herbst, 2005). The cleaning process is designed as a 
response to issues and discrepancies found during analysis rather than a preventative 
assessment procedure. Thorough checks are rarely done before the analysis in practice, 
which carries the risk of missing harmful issues. In this setup, only the issues detected by 
the analyst through dataset manipulation and analysis are addressed. This does not ensure 
that the assessment will cover all potential threats to the validity of analytical results in 
secondary use applications. For example, EHR-extracted clinical datasets may present 
issues such as missing and duplicate data appearing during the extraction process, which 
typically involves complex queries. Despite these potential problems, the data are rarely 
checked thoroughly for quality during the extraction process. Also, data cleaning is often 
driven by the purpose-independent application available testing tools (e.g., range 
checking, data validation and data format checking) rather than to detect potential threats 
to analytical results. This situation is much more alarming in the case of repurposed 
clinical data (Van Der Lei, 1991) because they are not specifically designed and recorded 
to satisfy secondary analytical needs. In such cases, issues may arise beyond the accuracy 
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and cleanliness of the data, such as not having the right variables to run the analysis or 
data that record implausible events. It is, therefore, imperative to conduct a systematic 
assessment of the data's suitability for a specific secondary use case prior to the 
secondary analysis (e.g., statistical analysis, exploratory visualization, etc.). Thus, data 
assessments of repurposed clinical data must cover a broad spectrum of potential issues 
rather than only those detected by the analyst.  
DQ assessment (Maydanchik, 2007a) is an alternate approach to data cleaning. Its goal is 
to help ensure valid analytical results through the evaluation of the dataset's ability to 
satisfy analytical needs (i.e., its fitness for purpose) (Holve, Kahn, Nahm, Ryan, & 
Weiskopf, 2013; Juran, 1962). This approach is usually carried out before performing the 
secondary analysis and the results serve as the basis to determine the dataset's strengths 
and weaknesses. It emphasizes the evaluation of the dataset for a specific application and 
is a more appropriate way of investigating a broader range of potential issues as 
compared to data cleaning. This approach is also very attractive for the secondary use of 
clinical data given that two purposes interact in such applications (Floridi, 2013): the 
primary purpose (i.e., recording the care of patients) and the secondary analytical purpose 
(e.g.,  prevalence estimation, clinical outcomes analysis, etc.). DQ assessments allow the 
user to evaluate whether the dataset will be good enough to provide reliable results for 
the secondary purpose, while still minding the primary purpose. 
Kahn et al. (M. G. Kahn et al., 2012) recently proposed a generalized framework to 
support a comprehensive and systematic approach to assess DQ for the purpose of 
building EHR-based Clinical Data Warehouse (CDW). However, there is a second stage 
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where systematic approaches for the assessment of DQ are currently unavailable.  These 
assessments aim to evaluate a subset of the CDW selected for a secondary analytical 
purpose (i.e., the analytical dataset). They typically focus on the independent and 
dependent variables directly related to the research question. A review of methods 
available for these secondary assessments (Nicole Gray Weiskopf & Weng, 2013) 
revealed that current methods are not generalizable, not systematic and fail to take the 
secondary analytical purpose into account. Moreover, it has been noted that one of the 
main barriers to the effective assessment and the transparent reporting of DQ results in 
secondary uses of clinical data are the ambiguity of DQ definitions (N. Weiskopf, 
Hripcsak, Swaminathan, & Weng, 2013) and the lack of a universally accepted set of DQ 
features to test for (M. Kahn et al., 2015). Making DQ requirements explicit would 
greatly support consistent DQ evaluations as well as clearer communication and reporting 
of DQ results. 
To address the current limitations in these methods I developed a framework with the 
following characteristics: 
• Supports purpose-specific DQ assessment 
• Provides a DQ assessment process that is:  
o Generalizable to a wide range of secondary use cases 
o Systematic (i.e., executed according to a fixed sequence of steps) 
• Makes DQ requirements explicit in order to: 
o Improve communication within the research team 
o Promote transparent reporting of DQ issues  
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1.3 - Dissertation Structure 
To create such framework I developed a purpose-specific DQ assessment process (i.e., 
DataGauge) that possesses the features stated above, along with a guidance framework 
for the development of comprehensive DQ assessments of repurposed clinical datasets. 
Then, I evaluated DataGauge’s ability to increase the number of DQ potential issues 
found before assessment. The dissertation is laid out in an analogous fashion. In Chapter 
2, I present a review of the current state of the science in DQ theory, DQ assessments at 
large and DQ assessments for the secondary use of clinical data to show current needs 
and gaps in the literature. In chapter 3, I describe the DataGauge process and its 
development. In chapter 4, I detail the development of the DQ assessment guidance for 
the definition of DQ requirements within DataGauge. In Chapter 5, I evaluate 
DataGauge's ability to identify more DQ issues than the current systematic standard 
method of DQ assessment for the secondary use of clinical data. The dissertation 
concludes by describing its significance and contributions to the field of clinical research 
informatics and clinical data reuse. 
1.4- Summary of Contributions 
My work lays the practical foundation for the systematic DQ assessment of repurposed 
clinical data as an evaluation of fitness for purpose (Holve et al., 2013). This contributes 
to supporting the reliable secondary use of clinical data (Charles Safran et al., 2007) 
which is a critical step towards building learning healthcare systems (Institute of 
Medicine (US) Roundtable on Evidence-Based Medicine, 2007). DataGauge provides a 
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stronger foundation for research aiming to learn from existing clinical data, generate 
novel yet data-driven research hypotheses and carry out cost-effective population-level 
analyses. It also provides guidance to support a thorough definition of DQ requirements 
for the secondary use of clinical data, which is currently missing in the literature. Lastly, 
it provides a method to explicitly define and encode DQ requirements. This is a first step 
towards supporting communication within the analytical team, because the process 
provides a tangible set of documents to help organize the team member's diverse 
backgrounds and expertise with respect to the secondary use case.  
This work innovates by breaking the current paradigm of data assessments for clinical 
data reuse, which is that ad-hoc, analyst-based, analysis-independent cleaning of data is 
sufficient to prevent misleading results in the reuse of clinical data. DataGauge proposes 
a new frame where repurposed datasets are to be assessed for their adequacy to answer a 
specific research question prior to analysis. DataGauge also stipulates that the 
assessments should be done by a team of experts in the domains of data science, statistics 
and medicine. This work supports cancer prevention by enabling a more trustworthy 
reuse of observational data from a broadly available yet still untapped data source: 
Electronic health records. EHRs are a very powerful source of knowledge that has the 
potential to enable the cost-effective analysis of population-level data. These databases 
will undoubtedly become an invaluable source of data for research fields such as cancer-
prevention in the near future due to the increasing number of recorded variables and 
imminent inclusion genomic data.  
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Chapter 2: Related Work 
Many tools are available for the secondary analysis of data but there are limited options 
to assess whether those data will yield valid results. To ensure that analytical valid 
results, one must ensure that the data accurately describe the observed objects and that 
they are likely to contain the necessary information (e.g., values, variables, sampling rate, 
etc.) to answer research question. Research shows that repurposed clinical data sources 
pose problems in both of these areas. These problems stem from measurement and 
recording processes (Aronsky & Haug, 2000) and inadequacies stemming from 
repurposing (Hersh et al., 2013). It is crucial to detect these issues before analysis in 
order to provide researchers with an understanding of data limitations and, in turn, the 
expected accuracy of analytical results. Such process is nothing more than the quality 
evaluation of a dataset, broadly known as a DQ assessment (Maydanchik, 2007a).  
2.1 - Data Quality Definitions, Frameworks and Assessment Tools  
DQ has been a subject of study for several decades in fields outside biomedical 
informatics (Dasu, 2013; Dentler et al., 2014, 2013; Madnick, Wang, Lee, & Zhu, 2009; 
Redman, 1998, 2013; Sadiq, 2013a; Trickey, 2012). Past research on DQ has produced 
definitions (Standardization, 1994), methods (Maydanchik, 2007a; Olson, 2003) and 
frameworks for DQ management (Fan, 2012; Sadiq, 2013b) and improvement (Batini & 
Scannapieca, 2006a, 2006c; Fan, Geerts, Ma, Tang, & Yu, 2013; Lee, Strong, Kahn, & 
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Wang, 2002; Redman, 2013; Wang & Strong, 1996).  This wealth of research provides a 
foundation for assessment during the data production cycle and is designed to support 
database administration work. In fact, most of this knowledge is geared towards 
supporting the maintenance of enterprise databases through DQ management (Redman, 
2013). This process entails the systematic assessment of whole databases according to 
user-defined rules (Maydanchik, 2007a) and flagging of common data issues such as 
duplicates and inconsistent input. Flagged data are then corrected using imputation 
methods or eliminated (Fan, 2012). The cycle is repeated to monitor and manage the 
quality of whole databases (Sadiq, 2013b). Though this research supports primary 
practical uses of data, it provides very little guidance for the assessment of repurposed 
clinical data.  
Quality is defined as the ability to satisfy needs (Standardization, 1994). Those needs are 
defined by an intended purpose. Thus, the most widely accepted definition of DQ is 
'fitness for purpose' (Holve et al., 2013; Juran, 1962). Three key features can be derived 
from this view of DQ. First, the quality of any dataset can only be measured with respect 
to a specific purpose. For example, a pre-Copernican, astronomical book would have 
very low DQ for its original purpose of understanding the laws governing the universe, 
but very high DQ for the secondary purpose of understanding the historical development 
of Ptolemaic astronomy (Floridi, 2013). Second, when repurposing data two purposes 
must be considered (Floridi, 2013): the original purpose for which the data were 
produced and the secondary purpose, which generally entails a secondary analysis to 
answer a specific research question. This means that the assessment for the secondary 
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purpose will necessarily have to take the initial purpose into account to define 
assumptions, expectations and evaluation parameters for the DQ assessment. Finally, 
systematically assessing quality in any industry or application requires a set of points of 
interest or DQ criteria. These criteria are represented by DQ requirements, which define 
specific conditions that the dataset must meet to be fit for purpose (Juran, 1962; 
Standardization, 1994). For example, the set of DQ requirements for assessing the quality 
of clinical data for treating individual diabetic patients is quite different from that needed 
when assessing the same data for the purpose of understanding the efficacy of a new 
diabetes treatment protocol. Routine clinical data from individual diabetic patients lacks 
randomization, controls, and systematic data collection.  Thus, DQ requirements should 
aim to define the ideal dataset for the intended purpose as a way to provide a standard to 
evaluate whether the data possesses the necessary features, such as an evenly sampled 
population, to obtain valid and acceptably reliable results. 
In practice, DQ assessments are carried out using a set of tools and techniques that aim to 
test for specific DQ issues. A large number of techniques are available in the literature to 
semi-automatically assess specific DQ issues (Borek, Woodall, Oberhofer, & Parlikad, 
2011; Maydanchik, 2007b). We will call these techniques DQ tests and define them as a 
tool, algorithm, approach or strategy employed to test the adherence of a dataset to a 
specific DQ requirement. They serve as a means to gather evidence of a dataset's fitness 
for purpose in light to a specific DQ criterion. Since these tests are geared towards 
identifying discrete problems, they are only capable of detecting issues at the data level 
such as typos, erroneous formatting or outliers. This output is useful to flag low-level 
  
 
13 
problems but rarely provide enough information on their own to decide whether a dataset 
is fit for purpose. This is why a DQ assessment can be defined as a judiciously selected 
combination of DQ tests based on DQ requirements to assess a dataset's fitness for a 
specific analytical purpose based on domain knowledge, data science, research design 
and analytical tools (e.g., statistical methods, machine learning algorithms, visualizations, 
etc.).  
Designing DQ assessments in an effective and reliable way is a challenging task because 
of the broadness of the question at hand: "Is this dataset good enough to yield valid 
results when analyzed to answer the research question?" To support this design process 
the literature provides frameworks that organize DQ knowledge and testing approaches 
(Batini & Scannapieca, 2006a, 2006b; M. G. Kahn et al., 2012; Lee et al., 2002; Madnick 
et al., 2009; Maydanchik, 2007a). One example is Wang & Strong's conceptual 
framework of DQ (Wang & Strong, 1996), which describe all aspects of DQ (i.e., DQ 
dimensions) that may be of interest to data consumers and classifies them into a 
taxonomy (see section 3.2.3 for full description). This work provides a list of aspects that 
should be considered to when evaluating DQ but the list is too abstract to be useful in 
domain-specific applications (Floridi, 2013; Nicole Gray Weiskopf & Weng, 2013). 
 Another example is Borek et al.'s classification of DQ assessment methods (Borek et al., 
2011). This framework organizes DQ testing approaches according to target DQ 
problems and database mapping requirements (i.e., data model subsets) as a way to 
support systematic selection (see section 3.2.3 for full description). This framework is 
helpful in three ways. First, it gives a limited list of potentially testable DQ issues and 
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provides clear testing approaches. Second, it helps to break down the complexity of the 
dataset into more manageable pieces. Third, by linking DQ issues and data pieces to a 
finite number of testing methods, it limits the scope of the DQ assessment design. For 
example, if we were to do a single variable check we could only use range checking, data 
validation, lexical analysis or column analysis according to this classification (Borek et 
al., 2011). Based on this limited set of methods it is much easier to select the correct 
method. However, this framework does not interface with Wang & Strong's DQ 
dimensions and does not provide any domain-specific support. In general, the available 
guidance lumps domain-knowledge-specific DQ test definition into a 'business rule 
definition' task that provides no clear process to follow (Maydanchik, 2007a). This setup 
fails to support the systematic definition of DQ tests because it provides no specific 
structure execute the task, leaving domain experts are to handle this task ad hoc. Also, 
DQ testing approaches (i.e., DQ test tools classifications) that aim to evaluate purpose-
specific issues are usually represented under the umbrella terms 'Domain Analysis' and 
'Semantic Profiling' (Borek et al., 2011) but fail to define them in specific terms. This 
guidance ultimately does not ensure the systematic and thorough definition of DQ tests to 
support systematic and thorough definition of purpose-specific DQ assessments.  
Thus, current DQ frameworks are still difficult to use for DQ assessment design and 
execution for three major reasons. First, there are large conceptual gaps between DQ 
theory and practice (Floridi, 2013). Second, major discrepancies and incompatibilities 
between nomenclature and DQ frameworks have been reported (Floridi, 2013; Nicole 
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Gray Weiskopf & Weng, 2013). Finally, the guidance tends to be abstract in nature and 
lack domain-specificity (Floridi, 2013).   
2.2 - Data Quality Assessment for the Secondary Use of Clinical Data 
It is well known that EHRs often contain inaccurate data and that accuracy varies 
between sites (Hogan & Wagner, 1997).  It is also broadly accepted that clinical data are 
incomplete (N. Weiskopf et al., 2013). This has been partially attributed to variable 
execution in data entry workflows as well as limited integration between healthcare 
institutions (Finnell, Overhage, & Grannis, 2011; Parsons, McCullough, Wang, & Shih, 
2012), so EHR data may not tell the patient's whole story. Also, some data contained in 
the record may not be easily accessible (e.g., clinical notes) (George Hripcsak et al., 
1995). The data may not be recorded at regular intervals or at a satisfactory rate for the 
secondary analysis (N. Weiskopf et al., 2013). Since EHR data is not intended for 
research, coding may not be sufficiently complete or accurate for research purposes 
(Bernstam, Herskovic, Reeder, & Meric-Bernstam, 2010; George Hripcsak, Knirsch, et 
al., 2011). Ultimately, the root of the problem seems to be that clinical data are created as 
a byproduct of clinical practice and therefore, may not follow the same production quality 
standard as research staff would for a clinical research project (Hersh et al., 2013). All 
these issues are symptoms of poor DQ with respect to research. Therefore, it is crucial to 
carry out thorough assessments to detect DQ issues before analysis and to consider 
identified issues when interpreting the analysis results. 
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Current DQ assessment methods have several limitations in the field of biomedical 
informatics. A recent systematic literature review (Nicole Gray Weiskopf & Weng, 2013) 
found that they are not systematic or generalizable and fail to adopt the preferred 'fit-for-
purpose' approach (Holve et al., 2013). They also fail to support the transparent reporting 
of DQ assessments results (M. Kahn et al., 2015).  Even though general DQ testing 
approaches found in the literature can be applied to the secondary use of data (Borek et 
al., 2011; Maydanchik, 2007b), their disparate nature and data-level (as opposed to 
purpose-level) focus makes them inappropriate to support the evaluation of fitness for 
purpose (M. Kahn et al., 2015; M. G. Kahn et al., 2012; Wang & Strong, 1996; Nicole 
Gray Weiskopf & Weng, 2013). To address this limitation, Kahn et al. have developed a 
framework, based on existing strategies and DQ tests, (M. G. Kahn et al., 2012) that 
supports the assessment of DQ for repurposed clinical data. This framework provides a 
process to run evaluations paired to a list of DQ rule-types to be considered by database 
administrators and researchers to define DQ requirements combined into a standard to 
detect poor quality data. Quality is assessed in relationship to the defined DQ standard by 
flagging the data that infringes on the defined DQ requirements. This process and DQ 
requirement development guidance sets the foundation for a generalized DQ assessment 
for cross-site aggregation of clinical data. Though this initial framework increases the 
potential for systematization for clinical data reuse, it is heavily oriented towards the 
initial data production purpose (i.e., health record keeping) and does not consider an 
analytical reuse purpose (e.g., answering a research question). This means that this 
framework does not allow the user to assess fitness for purpose if the intended data use is 
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anything but data aggregation.  For these secondary purposes, there are immensely large 
numbers of possible research questions to be considered, which complicates the 
definition of a general framework and systematic process to assess DQ.  
In response to the incoherent definition of DQ testing approaches and discrepancies 
between frameworks, an ontology for the DQ assessment of repurposed clinical data has 
also been recently published (Johnson, Speedie, Simon, Kumar, & Westra, 2015). This 
work rigorously defines concepts to enable the automated computation of DQ measures 
(i.e., quantitative evidence of DQ requirement infringements within a given dataset for a 
specific purpose) through the application of DQ tests. It also defines relationships 
between DQ dimensions and 19 DQ measure types that aim to unambiguously define and 
catalog all possible DQ tests for the secondary use of clinical data. However, this work 
has several limitations in supporting the effective DQ assessment of repurposed clinical 
data. First, it does not provide a general process for the systematic execution and 
implementation of DQ assessments. Second, it fails to provide guidance as to how to 
develop DQ assessments that ensure a reliable evaluation of fitness for purpose. Third, it 
fails to bridge the gap between purpose, DQ theory and domain knowledge for the 
definition of the DQ requirements. This step is crucial to DQ assessments because it 
informs the calculation of the DQ measures through the selection and definition of 
specific DQ requirements that, in turn, define the DQ tests. Beyond DQ dimensions and 
theory, the definition of DQ requirements depends on two information sources: (1) 
purpose, which is difficult to model due to its great variability and (2) the domain 
knowledge held by the experts conducting the research, which is difficult to fully include 
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in an ontology. Though the ontology includes placeholders for these parameters, it fails to 
provide any guidance on how to integrate and use them in practice.  
2.3 - Requirements for the Definition of a DQ Assessment Framework for the 
Secondary Use of Clinical Data  
Effective DQ assessment depends on the purposeful combination of DQ tests (and, thus, 
the definition of DQ requirements) to assess fitness for purpose. In fields outside 
biomedical informatics, definition of DQ requirements has proven challenging and 
frameworks have been used to support the design of such assessments (Fan, 2012; Lee et 
al., 2002; Madnick et al., 2009; Stvilia, Gasser, Twidale, & Smith, 2007; Wang & Strong, 
1996). A framework is currently available to support DQ assessments for the 
consolidation of multi-site clinical data into CDWs (M. G. Kahn et al., 2012). However, 
there is no framework to support DQ assessments for secondary analyses of clinical data. 
Given the current state of the science, such frameworks should at least (1) provide a 
generalizable and systematic method for assessing DQ consistently across datasets and 
purposes (Nicole Gray Weiskopf & Weng, 2013) and (2) support the purpose-specific 
assessment of repurposed data (Holve et al., 2013). In other words, the framework should 
encourage the definition of requirements and tests that evaluate the appropriateness of 
datasets for the research question at hand. Moreover, the necessity of a systematic 
approach to these assessments requires a unified yet general way to define and implement 
DQ assessments. Therefore, the framework must provide an unambiguous process to 
define and execute DQ assessments.   
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One additional limitation of current clinical data reuse practices is the tendency not to 
include detailed DQ assessment results in publications (N. Weiskopf et al., 2013; Nicole 
Gray Weiskopf & Weng, 2013). To address this, DQ assessment result reporting 
guidelines have been published (M. Kahn et al., 2015). These aim to promote 
transparency in published analyses through explicit reporting of employed DQ 
assessment methods and DQ results. The ultimate goal is to ensure a deeper, more precise 
understanding of repurposed clinical data limitations and, in turn, the analytical results. 
Defining all parameters and assumptions of the DQ assessment explicitly would facilitate 
the transparent reporting of DQ results in three ways. First, it would promote the 
unambiguous definition of DQ features to test. Second, it would promote the organized 
development of the DQ test lists, which would then facilitate the conversion into a 
publishable format. Lastly, using explicit DQ assessment documents would structure 
communication within the research team.  
Thus, a framework that addresses the current limitations of DQ assessments for the 
secondary use of clinical data should have the following characteristics: 
• Supports purpose-specific DQ assessment 
• Provides a DQ assessment process that is:  
o Generalizable to a wide range of secondary use cases 
o Systematic (i.e., executed according to a fixed sequence of steps) 
• Makes DQ requirements explicit in order to: 
o Improve communication within the research team 
o Promote transparent reporting of DQ issues  
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Chapter 3: DataGauge - A Model-Driven Process for the Systematic Assessment of 
Repurposed Clinical Data 
In this chapter, I present DataGauge, a generalized and systematic procedure for the 
analysis-specific assessment of DQ for repurposed clinical data that addresses the 
limitations in the state of the science reviewed in Chapter 2. I also present an example 
showing its uses and advantages. Finally, I discuss DataGauge's strengths and limitations.   
DataGauge consists of three stages: (1) Scope definition, (2) DQ specifications 
development and (3) Data processing according to these DQ specifications. DataGauge 
provides specific steps that can be applied consistently across analyses to promote the 
systematic assessment of DQ. It supports the purpose-specific assessment of DQ by 
generating DQ requirements and documentation specific to a particular research question. 
DataGauge relies on explicit standards and documentation, which promotes collaborative 
analysis by providing tools to structure communication within the analytics team and in 
published results. It also allows an iterative approach where the analytical scope and DQ 
standards are improved as the research progresses. Finally, DataGauge facilitates linking 
of DQ requirements to available assessment methods.  
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3.1 - Adapting a Model Driven Quality Assessment Process to Clinical Data  
Quality assessment methods are widespread in many domains outside biomedical 
informatics and usually address one or more of the needs stated in Chapter 2. Basic 
quality assessments rely on qualitative evaluations (e.g., satisfaction surveys), that 
provide measures of perceived quality (Nelson & Niederberger, 1990). This type of 
assessment is generally purpose-driven and developed based on a generalized set of 
guidelines (Gómez, 2009) to ensure validity. However, such approaches have a tendency 
to produce ad-hoc evaluations rather than systematic assessments. To counteract this, 
standards organizations such as the ISO have defined quality control standards (Walker & 
Gee, 2000) and methodologies (Dale, 2015; Evans & Lindsay, 1999; Juran, 1962; 
Taguchi, 1986) that require the definition of quantitative requirements and a systematic 
approach to test them. These standards require explicit design documentation that defines 
quality requirements to be met by the evaluated product. One particularly interesting 
research field that resulted from the creation of these engineering standards is model-
driven engineering (Schmidt, 2006). This field focuses on developing methods to support 
the explicit definition of formal requirements and their automatic evaluation. These 
model-driven methods enable the systematic, generalizable and purpose-driven quality 
assessments of software products based on explicitly defined quality requirements. Thus, 
this approach addresses similar challenges to those described in Chapter 2 for the quality 
assessment of software products. However, it has not yet been adapted to assess the DQ 
of repurposed clinical data, nor evaluated.  
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Model-driven software development and quality assessment is a well-developed branch 
of software engineering (Boytsov & Zaslavsky, 2013; Jordi Cabot, 2012; France & 
Rumpe, 2007; González & Cabot, 2014; Mayrand & Coallier, 1996; Whittle, Hutchinson, 
& Rouncefield, 2014). These similarities offer a unique opportunity to adapt these 
methods to the DQ assessment of repurposed clinical data. Beyond addressing the 
limitations of the current state of the science, translating these methods is advantageous 
because model-driven quality assessment methods follow the standards for systematic 
product quality control (Evans & Lindsay, 1999; Juran, 1962; Taguchi, 1986), which has 
proven useful in other fields. The adaptation of these methods is likely to be viable for 
two reasons: (1) Wang has shown that data can be evaluated for quality just like any other 
product (Wang, 1998) and (2) experimental model-driven approaches to data validity 
checking have been reported as successful in the context of structured data using finite 
state models (Mezzanzanica, Boselli, Cesarini, & Mercorio, 2011).  
To define such a process I assessed the commonalities between model-driven software 
quality assessment methods. The methods shared three high levels stages: (1) Evaluation 
of needs and scope definition (France & Rumpe, 2007; Kan, 2002; Mayrand & Coallier, 
1996), followed by (2) Explicit modelling of product specifications (i.e., the quality 
requirements) based on the needs (France & Rumpe, 2007; Kan, 2002; Mayrand & 
Coallier, 1996; Mezzanzanica et al., 2011; Whittle et al., 2014) and, finally, (3) 
Evaluation of the product based on the previously-defined requirements (Boselli, 
Cesarini, Mercorio, & Mezzanzanica, 2013; France & Rumpe, 2007; Kan, 2002; 
Mayrand & Coallier, 1996; Mezzanzanica et al., 2011). These three steps can be easily 
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adapted to the secondary use of clinical data as the following stages: (1) A data needs 
assessment that serves as a definition of the data scope and should include the analysis of 
the research question and a definition of the resulting data needs, (2) The specification 
development, which would include the specification of the data needs in an explicit 
model as well as the definition of DQ requirements and, finally, (3) the evaluation, which 
would entail the assessment of the data according to the DQ requirements.  
At the heart of this process lies the definition of explicit models to represent DQ 
requirements. Multiple languages are used to describe such requirements in model-driven 
software quality assessment. For example, Universal Modelling Language (UML) and the 
Object Constraint Language (OCL) are routinely used to define software requirements. 
(J. Cabot, Clariso, & Riera, 2008; Jordi Cabot, 2012; Jordi Cabot & Gogolla, 2012; 
Demuth & Hussmann, 1999; Pinet et al., 2011; Selic, 2004; Zubcoff, Pardillo, & Trujillo, 
2009). UML is also routinely used to describe databases and data models in practice 
through its entity-relationship diagrams (Selic, 2004). OCL is designed to fully integrate 
with UML and provides an additional layer of constraints on data models (Jordi Cabot & 
Gogolla, 2012). The combination of these two languages is a viable way of encoding DQ 
requirements in a standardized, unambiguous way, resulting in a unified DQ assessment 
specification model-based document.  
To refine this initial process for the DQ assessment of repurposed clinical data I carried 
out three assessments of repurposed clinical data.  The end result was a generalized 
process for the systematic DQ assessments based on UML entity-relationship diagrams 
  
 
24 
and OCL constraints that I have named DataGauge. The process is presented in the next 
section. 
3.2 - The DataGauge Process 
3.2.1 - Method overview 
Figure 1 illustrates the three stages of the analysis-specific DQ assessment method called 
DataGauge. The stages are: (1) Data Need and Scope definition, (2) DQ specifications 
development, and (3) Data processing according to these specifications. These three 
stages are composed of five steps: (1) Define needs based on the research question and 
analytical study design, (2) Develop a data needs model (DNM) where we formalize the 
data needs, (3) Develop analysis-specific DQ requirements based on the analytical 
purpose, the DNM and the dimensions of DQ, (4) Extract data from the source dataset to 
fit the DNM, and (5) Evaluate the extract according to the DQ requirements where we 
flag all data that infringes on the DQ assessment standard.  
DataGauge is a guide for DQ assessments that applies to most secondary uses of clinical 
data. It is designed to be carried out collaboratively by a team of domain experts (e.g., 
clinicians), data users (e.g., researchers, clinical personnel, etc.), informaticians, 
statisticians, and database administrators (Barlow, 2013). Such a team ensures input from 
all relevant perspectives. The team is expected to iterate over these steps several times to 
refine the specifications as the research progresses.  
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Figure 1 – Iterative analysis-specific DQ assessment method for the secondary use of 
clinical data. This process defines the general stages and steps for analysis-specific DQ 
assessment using data models and an analysis-specific DQ standard.  
 
3.2.2 - Stage 1: Data Scope Definition 
The initial stage defines the scope of research in terms of data. This is done in two steps.  
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Step 1: Research Question Analysis 
First, the domain expert and statistician must define the research question and analytical 
design. This dictates the data needs. Objects of relevance to the analysis are identified 
(e.g., patients, prescriptions, diagnoses, etc.) along with independent and dependent 
variables based on the research question (Tabachnick & Fidell, 2001). I define data needs 
as all variables and metadata necessary to achieve the analytical goal (i.e., answering the 
research questions). For example, if we are studying the relationship between weight and 
age, the domain expert will define a person object that will contain the necessary patient 
demographic variables (i.e., weight measurements and age) plus all additional covariates 
to be selected based on their analytical needs and clinical domain knowledge.  
Step 2: Data Needs Model Development 
The second step is to build a Data Needs Model (DNM) that defines the ideal analytical 
dataset. We define the DNM as a fully-specified, explicit representation of all data needs 
for the analytical purpose, including the relationships between data elements. For 
example, if we are investigating relationships between weight and age, a simplistic DNM 
may be defined as a single table containing 'Subject ID', 'Weight' and 'Age' variables, 
where each line represents a weight observation. The model serves as a design 
specification document and an unambiguous means of communication among team 
members. This model defines the scope based on analytical requirements. This marks the 
end of stage 1 that ensures agreement on the scope of work, the necessary data and its 
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context for a specific analytical purpose. Step 2 continues into the first part of stage 2, 
described next. 
3.2.3 - Stage 2: Specification Development 
The second stage consists of iteratively refining the DNM along with DQ requirements 
that, if met, would ensure fitness for purpose. These two elements fully specify a DQ 
assessment for a clinical data source and a specific analytical purpose. Step 2 concludes 
when the analytics team has a fully defined and is satisfied with the DNM version. The 
qualities of a satisfactory DNM are difficult to define generically because they heavily 
depend on the purpose. The experts in the analytics team must, therefore, decide when 
the DNM is ready. It is important to note that it may be useful to run additional iterations 
of the DataGauge process after the initial evaluation. The DNM can then be revised and 
further refined.   
This step is crucial for several reasons. First, it clearly defines the assessment scope. 
Second, it defines the object(s) of analysis fully and explicitly. Third, the DNM defines 
the variables and their relationships, but also assigns clinical meaning to them by 
grouping them into objects that make clinical sense such as patient, prescription and 
measurements. This provides a link between the source data, the analytical purpose and 
clinical domain knowledge.  Revisiting the weight and age relationship example, the 
'Patient ID' would be an identifier with no specific clinical meaning, but 'Weight' would 
be tied to an observation that is associated with an office visit in the medical record. The 
additional clinical workflow information allows the analytics team to relate the weight 
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variable to clinical domain and workflow knowledge.  Defining the DNM also supports 
the generation of DQ requirements by outlining a finite DQ evaluation space. For 
example, if there are no numerical variables in the data model, the team will not have to 
set numerical thresholds for range checks. To ensure systematicity, the DNM design 
should also be in at least third normal form (Kent, 1983) or, equivalently, follow a tidy 
data format (Wickham, 2014).  Although equivalent, we prefer the tidy data standard, 
because it defines the data format in terms that are easier for analysts and researchers to 
understand. These forms specify the observational units (modeled as different tables), the 
variables within a unit (columns of a table), and the observations of each unit (rows of a 
table), that allow the clear definition of data needs.  An example of tidy-data-compliant 
DNM is provided in the next section. A clear specification of these three elements is 
required prior to beginning step 3.  
 Step 3: Analysis-specific DQ requirements Development 
Once the analytics team has fully defined the DNM, the third step is the definition of an 
analysis-specific DQ standard composed of DQ requirements. I define the DQ standard 
as a document containing the full set of individual DQ requirements that fully describe a 
fit-for-purpose dataset for a specific research question and DNM. This document allows 
the analytics team to explicitly develop and agree on DQ for a particular case. The 
development of DQ requirements is task is complex because it requires the integration of 
multiple information sources (e.g., the DNM, the research question, DQ theory). To tease 
out this complexity, I first lay out the theoretical basis for the DQ requirement 
development in the next paragraphs as follows: (1) define DQ requirements by 
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differentiating them from inclusion/exclusion criteria, (2) explain how developing tidy-
data-compliant models helps the analytics team to tease out the DNM's complexity and 
make the variables of interest more accessible, (3) I then explain how the levels of data 
granularity (Oliveira, Rodrigues, & Henriques, 2005) contribute to a thorough definition 
of DQ requirements and lastly (4) I explain the role of the DQ dimensions (Wang & 
Strong, 1996; Nicole Gray Weiskopf & Weng, 2013) and their integration into the DQ 
requirement generation task. The last paragraph of this section describes the DQ 
requirement development procedure.   
I differentiate DQ requirements from inclusion/exclusion criteria by the object they 
define and their goal. Inclusion/Exclusion criteria focus on the main object of interest to 
the research question (e.g., patients, encounters, visits, prescriptions, etc...). They aim to 
define the features that qualify or make these objects unacceptable for the study. These 
criteria aim to define a cohort or population. For example, if patients are the objects of 
study, inclusion/exclusion criteria will be based on demographic and clinical 
considerations. The object of analysis will usually be a patient for clinical research 
question but may also be encounters, visits, clinical notes, etc. for quality improvement 
and other projects. On the other hand, DQ requirements define the minimum expectations 
of data to ensure that a specific dataset is valid and useful for a specific analytical 
purpose. They aim to define a fit-for-purpose dataset. For example, "patient is at least 18 
years old" is an inclusion criterion whereas "patient date of birth is earlier than 
observation date" is a DQ requirement.  Each DQ requirement corresponds to a DQ test 
that will be carried out. For example, if our secondary analytical purpose included 
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assessment of weight change over time, a requirement might be 'patients must have at 
least two weight measurements'. To test this, I would check that there are enough patients 
with at least two weight measurements in the dataset for the secondary analysis (i.e., the 
dataset has an adequate sample size). If the condition is not met, the dataset is not fit for 
this particular analysis.  
DNMs often describe multiple aspects of a phenomenon, which can yield complex 
datasets. For example, a dataset for the secondary use of clinical data may contain cohort 
identification variables (i.e., variables that define patient characteristics and support their 
classification), outcome definition variables, exposure variables and relevant covariates 
(M. Kahn et al., 2015). To address this complexity we propose two strategies: the 
development of DNMs in the tidy data format (Wickham, 2014) and the decomposition 
of the DNM into levels of data granularity, described in the next paragraph (Oliveira et 
al., 2005). The requirements for a tidy dataset are "each variable reside in a column", 
"each observation is presented in a row" and "each type of observational unit is a table". 
In such form it is easy to isolate meaningful segments of the data model that correspond 
to variables and elements relevant to purpose. For example, let us build a DNM 
describing the necessary data to examine the relationship between patient demographics 
and patient weights over time. We may begin with a dataset that describes patients and 
their weight measurements and get the data in non-tidy-data-compliant formats; for 
instance, one line per weight measurements with all patient data attached to every line or 
one line per patient with multiple columns for weight measures. Neither of these forms is 
tidy-data-compliant because they combine two observational units in one table: patients 
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and weight measurements. Each observational unit must have a separate table. This 
means that we must necessarily have one table for patients and we must have a table for 
weight measurements. Also, each observation must be recorded as an individual row; 
this means that the database must contain one line per patient in the patient table and one 
line per weight measurement in the weights table. Finally, tidy-data standards require that 
each variable must be recorded in a distinct column. This means that the weights table 
must record the patient identifier, the weight value, the unit, a timestamp and any 
additional information as distinct columns. The same applies for the patient table where 
each column would correspond to a demographic variable. In the end we would have two 
tables: a patient table with all demographic variables (e.g., gender, date of birth, etc.) and 
a table with weight values and additional variables as described above. These two tables 
should be related to each other via a patient identifier, which plays the role of a primary 
key to the patient table and a foreign key to the measurements table. This data format 
makes patient demographics and weight measurement accessible for analysis and DQ 
assessment.  
A model with accessible variables also allows the team to view the DNM as a 
combination of data elements along a scale of data granularity (Oliveira et al., 2005). I 
define data granularity as the different data levels at which the objects of interest (i.e., 
patients, outcomes, drug exposures, etc.) can be encoded into the DNM. Some examples 
of these levels are: single value, multiple values, observation, observational unit and 
dataset. The benefits of providing a way to break down the DNM into simpler data 
elements are twofold. First, it reduces the complexity of the elements to assess. Second, it 
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allows the use of DQ test selection guidance. Borek et al. (Borek et al., 2011; Oliveira et 
al., 2005) have mapped these levels of data granularity to DQ test methods (i.e., ways to 
check the data based on DQ requirements). This mapping reduces the number of possible 
tests to be applied by giving the DQ assessment designer a limited number of testing 
approaches to choose from. In essence, this work maps usual DQ problems (e.g., missing 
values, inconsistent data formats, incorrect values, etc.) to DQ testing approaches (e.g., 
range checking, data validation, lexical analysis, etc.), classifying their usefulness by data 
granularity level (e.g., single value, multiple values, observation, etc.). This is a good 
starting point for a systematic DQ assessment design strategy because it tasks the 
analytics team with reviewing a finite number of data elements, for a finite number DQ 
testing strategies.  Its core weakness is that it does not map to DQ dimensions. 
To define an assessment that evaluates fitness for purpose, it is necessary to account for 
all dimensions of DQ (Wang & Strong, 1996; Nicole Gray Weiskopf & Weng, 2013). 
The theoretical dimensions have been formally defined by Wang & Strong in their 
conceptual framework of DQ (Wang & Strong, 1996) based on aspects that may be 
important to data consumers. They fall into four distinct categories: (1) Intrinsic DQ 
refers to the qualities that the data should have regardless of their purpose, (2) Contextual 
DQ focuses on the qualities that the data should have, based on the purpose for which 
they will be used, (3) Representational DQ includes data modeling and information 
display, and (4) Accessibility DQ focuses on having data that are readily available to be 
processed and yet accessible by authorized users. Intrinsic DQ encompasses accuracy, 
believability, objectivity and data source reputation (Wang & Strong, 1996). These 
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dimensions relate closely to the initial purpose for which the data were produced rather 
than the secondary analytical purpose. On the other hand, contextual DQ relates to the 
purpose for which the data are to be used. Dimensions of completeness, relevancy, 
timeliness, quantity of data and added value in the context of the intended purpose 
constitute contextual DQ. These dimensions are particularly useful when assessing the 
fitness of a specific dataset for secondary analysis. DQ requirements should be built 
around these dimensions keeping the analytical purpose in mind. In practice, the 
assessment should also include data checks to ensure the accuracy and believability of 
the repurposed dataset in case preliminary DQ assessments of primary purpose failed to 
catch errors that may adversely impact the analysis. When combined with the DNM at 
different levels of data granularity and the analytical purpose, these dimensions are the 
key to a comprehensive analysis-specific DQ assessment. This will be illustrated in the 
following section. 
Step 3 consists of reviewing the data model at all levels of data granularity to define the 
DQ requirements in terms of DQ dimensions and the analytical purpose. These 
requirements are assigned to specific DQ assessment methods (Borek et al., 2011) 
according to potential DQ issues and the level of data granularity (Oliveira et al., 2005). 
The team surveys the DNM in light of DQ dimensions to define the minimum standard of 
quality for a particular analysis. For example, if studying the relationship between patient 
weight and age, the domain expert should define criteria relating to the plausibility of the 
weight variable such as "weights are positive numbers", but also relating to the 
completeness of the dataset such as "each patient should have at least one weight 
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measurement" and so on. Each requirement will be mapped to a specific DQ checking 
method based on the assessed DQ dimension and data granularity level. We provide a 
table linking DQ dimensions, data granularity and DQ testing approaches to facilitate this 
(Table 1). We built this guidance table as a combination of Borek's et al.'s (Borek et al., 
2011) classification of DQ testing approaches and the DQ dimensions relevant to the 
secondary use of clinical data defined by Weiskopf et al. (Nicole Gray Weiskopf & 
Weng, 2013) (i.e., correctness, completeness, concordance, plausibility and timeliness). I 
included an additional 'representation' dimension to assess the issues of data 
transformations and fit of the available data to the DNM specifications.  This dimension 
accounts for database design considerations being respected in the dataset (e.g., primary 
and foreign key checks).  
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Table 1 - DQ requirement development guidance table. This table links DQ dimensions, 
levels of data granularity and DQ testing approaches as a way to provide an overview or 
'menu' of the testing strategies at the disposal of the research team.  
 
3.2.4 - Stage 3: Data Processing 
This last stage uses the DNM and analysis-specific DQ standards to extract, format and 
assess the data. 
 Step 4: Data Extraction and Fitting 
The fourth step uses the DNM to guide the data extraction from the original database and 
to fit the data into the format defined in the specifications. The database administrator 
creates a schema with tables matching the DNM then loads the source clinical data into 
the tables. This schema should have all database rules such as variable type definitions, 
primary key rules, table relationship rules and other data validation triggers built in. 
Using this predefined schema to load the extracted data ensures that the values match the 
 Data Quality Dimensions 
Data Granularity 
Levels 
Correctness and 
Plausibility Completeness Concordance Representation Timeliness 
Cell/Value Domain analysis,  
Data Validation, 
Lexical analysis 
Domain Analysis, 
Lexical Analysis 
Domain Analysis  Column Analysis,  
Lexical Analysis, 
Schema Matching 
Domain Analysis 
Column/Variable Column Analysis,  
Data Validation, 
Semantic Profiling  
Column Analysis, 
Domain Analysis 
Column Analysis,  
Data Validation 
Column Analysis, 
Schema Matching  
Column Analysis, 
Domain Analysis  
Line/Observation Domain Analysis, 
Semantic Profiling 
Domain Analysis, 
Semantic Profiling 
Domain Analysis, 
Semantic Profiling 
Domain Analysis, 
Schema Matching  
Domain Analysis, 
Semantic Profiling  
Table/Observational 
unit 
Domain Analysis Domain Analysis, 
Column Analysis 
Column Analysis, 
Semantic Profiling  
Schema Matching Semantic Profiling, 
Domain Analysis 
Multiple Tables/ 
Dataset 
Semantic Profiling,  
PK/FK analysis,  
Column Analysis  
Domain Analysis, 
Semantic Profiling 
Domain Analysis, 
PK/FK Analysis,  
Semantic Profiling 
Column analysis, 
PK/FK Analysis, 
Semantic Profiling, 
Schema Matching 
Semantic Profiling, 
Domain Analysis 
Multiple Databases/ 
Multiple Datasets 
Semantic Profiling,  
Domain Analysis,  
Column Analysis 
Domain Analysis, 
Semantic Profiling 
Semantic Profiling,  
Domain Analysis  
Column analysis, 
Schema Matching, 
Semantic Profiling  
Semantic Profiling, 
Domain Analysis 	
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agreed upon data model, variable types and database relationships.  This step is an initial 
representational DQ test; if the data are not in the right format or variable types do not 
match, the database software should produce an error.  
Step 5: DQ Evaluation 
The fifth and last step consists of evaluating DQ based on the previously defined DQ 
requirements. Appropriate DQ test methods (Maydanchik, 2007b) are selected and 
implemented to test each DQ requirement. This process evaluates DQ standard 
compliance and flags discrepancies. These flags allow further analysis, data diagnosis 
and imputation (Van den Broeck et al., 2005). Several indicators (i.e., DQ measures) can 
be calculated from these flags as measures of DQ (e.g., compliance percentage for each 
variable or patients with no data flaws divided by the total number of patients). These 
results provide quantitative evidence of non-compliant data and can serve as a basis for 
experts to judge the fitness for purpose.  
 3.3 - Example 
We used DataGauge to assess DQ for a repurposed clinical dataset and address the 
challenges of analysis-specific DQ assessment. The analytical purpose was to determine 
whether prednisone, a commonly-prescribed corticosteroid, is associated with weight 
gain. We chose this association because weight gain is a known and clinically-significant 
side effect of prednisone (PredniSONE Tablets [Package Insert], 2012) that is likely to be 
detectable through retrospective review of clinical data. Our data source was a CDW 
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containing routinely recorded clinical data from six academic outpatient clinics in a large 
metropolitan area in the southern United States. 
We used a UML-based database modeling tool (MySQL workbench data modeler; Oracle 
Corp., Redwood Shores, CA) to develop the DNM. A team composed of a clinician, a 
statistician and an informatician (the author), who also played the role of database 
administrator, developed the final UML diagram for the research question (Figure 2c). A 
series of models were iteratively created and discussed according to their ability to satisfy 
the analytical purpose as well as data availability in the CDW. Note the changes that led 
to the final data model in Figure 2 and the variations in DQ requirements per iteration in 
Table 1. Figure 2 shows variables that were removed because they were unavailable in 
the CDW (e.g., no drug exposure variable was found or could be reliably calculated from 
our CDW data). Figure 2 shows the evolution of the DNM from (a) single-table format 
that is not tidy data-compliant into (b) a tidy data compliant model with four 
observational units (i.e., Patient, Visit, PrednisonePrescription and Weight). The final 
DNM (c) improves on the tidy-data compliant model by removing the Visit observational 
unit, which is not directly relevant to the research question, and adapted the model to the 
data available in the CDW (e.g., changes in the variables describing the prednisone 
prescription). Our final model conforms to the tidy data guidelines (Wickham, 2014) 
providing one observational type per table (i.e., patients are represented as a separate 
table from weights and prescriptions), each line represents an observation (i.e., each line 
on the patient table a different patient, and in the prescription table a different 
prescription) and each variable corresponds to a column (e.g., patientID, gender and DoB 
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are separate variables in the patient table); this data format also corresponds to the third 
normal form (Kent, 1983). The final DNM served as a data specification document to 
guide the data extraction. Database tables were created to match the DNM and the raw 
data were extracted from the source database into the DNM schema using standard SQL 
queries. DQ requirements were defined in the form of Boolean expressions and Object 
Constraint Language constraints (Jordi Cabot & Gogolla, 2012). We chose OCL due to 
its integration with the UML diagrams previously used for the data models (Demuth & 
Hussmann, 1999; J. Cabot, Clarisó, & Riera, 2014; Seiter, Wille, Soeken, & Drechsler, 
2013).  
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Figure 2 - Evolution of the data needs model for the purpose of assessing a relationship 
between prednisone and weight gain using repurposed clinical data. This data model 
defines the data needs for the evaluation of an association between prednisone and weight 
gain. a), b) and c) show the three versions of the DNM for the each iteration. 
a)#
b)#
c)#
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We generated DQ requirements iteratively and collaboratively. Each DQ dimension was 
surveyed at different levels of data granularity (e.g., single value, multiple values, 
observation, observational unit, dataset, etc. (Oliveira et al., 2005)) running through all 
variables of the DNM and using the overview provided in Table 1 to guide the process. 
For example, when we combined the accuracy dimension with the single value level for 
the final DNM we came up with requirements such as "Dose must be positive" or "Refills 
must be positive or 0"; both of these requirements were mapped to a range checking 
method. The concordance dimension at the observation level yielded criteria such as "the 
prescription date should be later than the patient's date of birth" which was mapped to the 
semantic profiling DQ check method. At the observational unit or table level we assessed 
the timeliness of the data with the "Patient has a second weight measurement within 4 
months of the first prescription" requirement. This requirement was also mapped to the 
semantic profiling check method. DQ requirements were generated until the analytics 
team was satisfied with the DQ standard. We used the DQ requirements to evaluate the 
quality of the extracted data based on the third version of the DQ standard. We covered 
analysis-specific DQ requirements as well as generic requirements to test accuracy and 
believability of the data. Of 52 requirements, 17 were analysis-specific. Analysis-specific 
requirements tended to be more complex and concern a larger number of variables. Table 
2 shows how the requirements evolved over iterations; note the increasing precision and 
analysis-specificity (e.g., "2 values per patientID" in iteration 2 followed by "50% 
patients with 2 weight measures within 4 months of first prescription"). Each new DNM 
represented a specific data model designed to satisfy the same analytical purpose; each 
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iteration for the DQ requirement created an increasingly complete, refined and analysis-
specific set of requirements. 
Table 2 - Data quality requirement examples. The table shows DQ requirement examples 
as they were generated. The requirements became more specific and analysis-specific as 
the development progressed.  
 
The DQ tests revealed several DQ flaws. We were able to identify specific DQ issues 
such as inaccuracies (e.g., 84 weight values were above 400kg), inconsistencies (e.g., 56 
instances where weight changed more than 20% over 2 days) and incompleteness (e.g., 
43,135 patients with less than two weight measurements within 3 months of the 
prescription). This showed the approach's effectiveness at catching DQ issues and 
screening data at the basic data level. We also excluded 14.1% of the patient records as 
Iteration	 DQ	Dimension	 Variable	
Granularity	
Variable(s)	 Analysis	
Specific?	
Requirement	 DQ	assessment	
method	
DQ	Result		
(%	compliance	
or	Pass/Fail)	
1	 Accuracy	 Value	 Gender	 No	 In	{'M','F','U'}	 Data	Validation	 99.99	
	
	
	
	
	
	
Accuracy	 Value	 WeightValue	 No	 >0	 Range	Checking	 92.65	
Believability	 Value	 WeightValue	 No	 <400	 Range	Checking	 99.95	
Accuracy	 Value	 Strength	 No	 >0	 Range	Checking	 97.37	
Believability	 Value	 Strength	 No	 <2*[Max	dose]	 Domain	Analysis	 100	
Accuracy	 Value	 Dose	 No	 >0	 Range	Checking	 51.68	
Believability	 Value	 Dose	 No	 <2*[Max	pills	at	min	strength]	 Domain	Analysis	 100	
Accuracy	 Value	 Refills	 No	 >=0	 Range	Checking	 100	
2	 Accuracy	 Value	 WeightTime	 No	 >[System	Installation	Date]	 Data	Validation	 100	
	 Accuracy	 Column	 PatientID	 No	 Unique	 Column	Analysis	 100	
	 Concordance	 Line	 WeightTime,	DoB	 No	 Timestamp>DoB	 Domain	Analysis	 100	
	 Concordance	 Line	 PrescDTTM,	DoB	 No	 PrescDTTM>DoB	 Domain	Analysis	 100	
	 Concordance	 Table	 PatientID,	
WeightTime,	
WeightValue	
Yes	 Patient	weights	on	prescription	date	are	less	
than	2%	apart	
Domain	Analysis	 92.45	
	 Completeness	 Table	 PatientID,	
WeightValue	
Yes	 2	weight	measurements	per	patient		 Domain	Analysis	 85.92	
	 Completeness	 Line	 PatientID,	
WeightTime	
Yes	 Patient	has	weight	measurement	on	
prescription	date	
Domain	Analysis	 97.54	
	 Timeliness	 Table	 PatientID,	
WeightTime	
Yes	 Patient	has	second	weight	measure	within	4	
months	of	prescription	
Domain	Analysis	 48.62	
3	 Amount	of	data	 Table	 Strength,	Dose,		
Days,	Refills	
Yes	 Can	calculate	total	milligrams	prescribed	for	
50%	of	prescriptions		
Domain	Analysis	 Failed	
	 Amount	of	data	 Table	 Patient,	PRN	 Yes	 Less	than	25%	PRN	prescriptions	 Domain	Analysis	 Passed	
	 Amount	of	data	 Dataset	 PatienID,	
WeightTime	
Yes	 50%	patients	2	weight	measures	within	4	
months	of	first	prescription	
Domain	Analysis	 Failed	
	 Completeness	 Dataset	 PatientID,		
WeightValue,	
WeightTime,	
PrescriptionTable	
Yes	 Patients	with	at	least	2	unflawed	weights	
after	an	unflawed	prescription	
Domain	Analysis	 13.1	
	 All	 Dataset	 All	Variables	 No	 Patient	records	with	no	general	DQ	flaw	 Domain	Analysis	 2.93		
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they contained a single weight measurement and weight gain can only be calculated with 
two or more. We flagged all data items that violated DQ criteria and then calculated the 
number of patients with no flagged data in their records, having at least two weight 
measurements after their first prednisone prescription. Thus, only 2,379 patients out of 
80,990 (13.1%) could be confidently used for analysis. The massive censoring of patient 
records is likely to bias in the final dataset used for analysis and potentially render 
subsequent analytical results unreliable. Also, in this particular case we are looking at a 
commonly prescribed drug and a broad population. However, large clinical datasets are 
often used to investigate features of rare diseases and specific cases for which few 
patients records may qualify. This high level of censoring could drastically reduce the 
sample size to levels inadequate for secondary statistical analyses.  
This example illustrates how DataGauge can advance current practices in DQ assessment 
for the secondary use of clinical data. First, DataGauge provides an analysis-specific DQ 
assessment method. We showed a way to define DQ requirements based on the DNM, 
which is dictated by the analytical purpose, but also to define them based on the intended 
purpose. For example, "2 values per patientID" is a DQ requirement that depends on the 
DNM, but also relevant to the analytical purpose because two weight measurements are 
necessary to detect change over time.  
DataGauge is general because it can be applied across cases by generating new analysis-
specific DNMs and DQ standards. Second, DataGauge provides guidance for DQ 
standards and tool selection by allowing a DNM to be decomposed into multiple pieces. 
Paired to potential DQ issues, these pieces can be mapped to specific DQ test tools and 
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standards (Borek et al., 2011; M. Kahn et al., 2015). In surveying the DNM at multiple 
levels of granularity we were able to identify the DQ requirements. The levels of data 
granularity informed method selection by explicitly listing and reducing number DQ tests 
that could be applied. For example, if we were to do a single variable check we could 
only select from range checking, data validation, lexical analysis or column analysis 
(Borek et al., 2011). Based on this limited set of methods and the actual requirement it is 
much easier to select the correct method.  
The DNM in the tidy data format allows the research team to clearly identify variable 
types (e.g., cohort definition, exposure, covariates, etc.) to organize their requirements 
and results to match current DQ reporting standards (M. Kahn et al., 2015). Finally, the 
application of DataGauge provides explicit documentation (i.e., a DNM and a DQ 
standard) that can structure the communication among team members. These documents 
can be evaluated, discussed and improved as the work progresses. The team can focus on 
analytical needs and research goals to develop a model that is then refined by the 
constraints of data availability.  
3.4 - Conclusion 
I have presented DataGauge, an iterative team-based method to carry out analysis-
specific DQ assessments for the secondary use of clinical data. DataGauge requires five 
steps: (1) Define needs based on the research question and analytical study design, (2) 
Develop a DNM where we formalize the data needs, (3) Develop analysis-specific DQ 
assessment requirements based on the analytical purpose, the DNM and the dimensions 
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of DQ, (4) Extract data from the source dataset to fit the DNM, and finally (5) Evaluate 
the extract according to the DQ requirements. DataGauge addresses limitations in the 
state of the science of analysis-specific DQ assessment for the secondary use of clinical 
data by providing a systematic and analysis-specific approach. DataGauge is designed to 
be a general DQ assessment process, as its steps can be applied to any dataset and 
analytical purpose. It is purpose-specific because the first two stages are dedicated to 
capturing the complexities of the research question at hand and developing assessment 
documents to fully specify a purpose-specific DQ assessment. These documents describe 
the assessment's assumptions and parameters explicitly. Finally, DataGauge supports 
systematicity because it allows the consistent definition and implementation of DQ 
assessments. Variables of interest and DNMs are defined in a systematic way; however, a 
systematic definition of DQ requirements would require further support due to the its 
complexity (i.e., combining research question, DMN, DQ theory and domain knowledge 
to define requirements).   
We have provided preliminary guidance for the development of a well-defined DNM and 
analysis-specific DQ requirements. This guidance combines knowledge from the 
literature about the link between DQ dimensions relevant to the secondary use of clinical 
data, levels of data granularity and DQ testing approaches. It provides an overview of the 
general DQ dimensions to consider, data granularity levels that support the 
decomposition of the DNM into more manageable pieces and provides DQ testing 
approaches for each DQ dimension-data granularity level combination. This guidance is 
useful because it provides a finite set of aspects to consider when developing DQ 
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requirements for a specific purpose and maps them to specific testing approaches.  
However, it was difficult to determine whether the definition of DQ requirements had 
covered all relevant aspects. Ensuring this is critical because the efficacy of the DQ 
assessment at catching DQ issues is dependent on the comprehensiveness of the DQ 
standard. We have provided four preliminary guides to support the development and 
testing of DQ requirements based on previous work: 1) a tidy data format organize data 
models in such a way to make variables accessible (Wickham, 2014), 2) a scale in levels 
of data granularity to break down the DNM's complexity (Oliveira et al., 2005), 3) a 
mapping between levels of granularity and available DQ check methods (Borek et al., 
2011) and 4) the dimensions of DQ that dictate the aspects to consider when testing 
fitness for purpose (Wang & Strong, 1996). DataGauge integrates prior work into a single 
procedure that guides the user to explicitly define their data needs and DQ requirements. 
However, there are still challenges in defining DQ requirements comprehensively. We 
attribute this to three reasons: (1) The DNM, the data granularity levels and the DQ 
dimensions don't fully define the problem space to define all DQ requirements, (2) the 
DQ dimensions are vague (e.g., there are multiple definitions of completeness (N. 
Weiskopf et al., 2013)) and (3) the DQ dimensions are too far removed from clinical 
domain to be useful in secondary use applications. Thus, further work is needed to 
develop domain-specific guidance for the definition of analysis-specific DQ standards. 
Such work would ensure a thorough and systematic development of DQ requirements 
and, in turn, more reliable DQ assessments. In the next chapter, we describe the 
development of such guidance. 
  
 
46 
 
 
Chapter 4: A Guidance Framework for the Development of DQ Requirements 
DataGauge is designed to enable systematic, purpose-specific DQ assessments by 
providing a general process to implement DQ evaluations across repurposed datasets and 
research questions. However, the systematicity of a DQ assessment can only be fully 
ensured if the analytics team is provided with a way to generate the DQ requirements 
comprehensively and consistently. In fact, DQ assessments can be defined as a 
judiciously selected combination of DQ tests based on DQ requirements. This means that 
the definition of DQ requirements is the key component of the assessment's design. 
Generating such requirements can be a daunting task because it requires integrating 
multiple information sources: the research question, the DNM, DQ theory and the domain 
knowledge necessary to interpret the other three elements. Though the current version of 
DataGauge provides some support to address this (e.g., DQ dimensions (Wang & Strong, 
1996) and a classification of DQ test approaches (Borek et al., 2011)), the generation of 
DQ requirements remains a complex task. This complexity threatens the systematic 
definition of DQ requirements. Thus, further guidance to support this task is needed. 
There is very little literature available to guide the development of purpose-specific 
requirements and the available guidance presents three key limitations: (1) the DQ 
requirement generation process is not described in detail (Maydanchik, 2007a), (2) the 
guidance provides no specific structure to address the task systematically, implying that 
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experts should execute this task ad hoc (Borek et al., 2011; Lee et al., 2002; Wang, 1998) 
and (3) purpose-specific DQ testing approaches are usually lumped under the umbrella 
terms 'Domain Analysis' and 'Semantic Profiling' (Borek et al., 2011), which ultimately 
don't provide transparent guidance.  
A similar situation exists in biomedical informatics, where very little guidance exists to 
support fitness-for-purpose assessments (Holve et al., 2013). The literature provides three 
pieces of guidance. First, DQ dimensions have been adapted to the secondary use of 
clinical data that provide some support (Nicole Gray Weiskopf & Weng, 2013) but 
remain vague, ambiguous and removed from the clinical domain (N. Weiskopf et al., 
2013). Second, an assessment framework that provides guidance as to what types of 
general checks can be performed on clinical data has been published (M. G. Kahn et al., 
2012). This guidance fails to include considerations about the purpose or the domains of 
expertise that come into play when making secondary use of clinical data (Barlow, 2013). 
Finally, the DQ ontology for the secondary use of clinical data (Johnson et al., 2015) 
provides some insight as to which types of tests that can be used to assess fitness for 
purpose. Even though, providing such list of possibilities is useful, the interplay of 
complex information sources (i.e., dataset and domain knowledge) as well as the inherent 
vagueness of the research purpose and DQ dimensions still make this work unlikely to 
support the systematic generation of DQ requirements for a specific research question 
and a specific dataset.  
Three key challenges result from this state of the science; they are also relevant the 
current guidance provided by DataGauge. First, the original guidance posed problems 
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because it is abstract and too far removed from the knowledge domain of application. In 
other words, the DQ dimensions (Wang & Strong, 1996; Nicole Gray Weiskopf & Weng, 
2013), data granularity types (Borek et al., 2011) and DQ testing approaches 
(Maydanchik, 2007a) do not provide any guidance about the kinds of threats that affect 
data based on clinical domain or EHR data knowledge. For example, if we were assessing 
concordance in weight values within a day, and detected a 30% increase, this would 
clearly be a problem based on clinical knowledge (i.e., patient weights don't fluctuate that 
much over the course of a day) whereas this would not be a problem if we were assessing 
the systolic blood pressure measurement values; systolic blood pressure varies 
considerably over a day. Current literature provides no guidance on this type of 
distinction and lacks explicit structure to facilitate the detection of such issues through 
the integration of expert knowledge. Second, the current guidance does not provide a 
clear overview or list the aspects to be reviewed to ensure a comprehensive and 
systematic generation of DQ requirements. Though DataGauge provides a limited list of 
items to assess when combined with the DNM, it fails to include important dimensions 
such as the expertise involved in defining DQ requirements. An overview would help the 
analytics team track the coverage of DQ assessment aspects and potential DQ threats to 
be considered. Though the list of DQ criteria, data types, variables in the DNM and DQ 
testing approaches provided a finite list to review, it does not identify specific DQ threats 
in repurposed clinical data. Finally, the DQ dimensions that aim to guide the requirement 
generation are vague. For example, completeness could be interpreted in multiple ways 
(N. Weiskopf et al., 2013). If completeness was thought of as overall completeness (i.e., 
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the overall number of recorded observations), DQ requirements such as "patients must 
have at least X measurements" could be defined. In contrast, completeness is sometimes 
thought of in statistical terms, a corresponding requirement could be defined as "the 
dataset must contain enough observations to provide adequate statistical power".  
Based on these limitations, this framework should possess three features.  First, it should 
provide a finite list of potential aspects to consider while developing DQ requirements for 
a specific dataset and research question. This list should serve as an overview to the DQ 
requirement generation process. Second, it should provide a way to bridge domain 
knowledge and the DQ requirement generation task. Third, it should list issues and 
threats that the requirements should check for in a specific way.  
To develop such guidance, I did a preliminary review to define the most frequent analysis 
types and clinical data types employed in clinical data reuse projects. I based my work on 
a literature review article and a set of clinical data request tickets. I then asked a clinical 
expert to define research questions based on their secondary use activities. These served 
as use cases. The six final use cases covered 90% of the most common analyses and 
clinical data types revealed by the literature review and clinical data request tickets. I 
then applied DataGauge to these six use cases in order to answer the following question: 
What criteria should be considered when assessing DQ for repurposed clinical data? The 
resulting DQ requirements represented a broad range of issues to test for when making 
secondary use of clinical data. Based on the generated DQ requirements, I defined an 
overview to guide DQ requirement generation in the form of a checklist. This overview 
partitions the problem space by knowledge domains and aspects of clinical data to bridge 
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the gap between task and domain knowledge. I also provide a list of specific questions to 
guide the generation of DQ requirements within each task of the overview checklist. The 
questions provide requirement-level guidance to ensure the coverage of specific DQ 
issues that may threaten fitness for purpose.  
In this chapter I describe the methodology and results of my DQ requirement 
development guidance efforts. First, I describe the process used to define six use cases 
that cover most applications and data types used in clinical data reuse projects. Then I 
describe the methodology that I used to develop the guidance framework based on the 
application of DataGauge to these use cases; a presentation of the results follows. I then 
describe the general guidance framework and I give an example of its use. Finally, I 
discuss the contributions, strengths and limitations of this work as well as future 
development directions.  
4.1 - Defining Secondary Use Coverage 
Clinical data are routinely repurposed for a vast number of applications, so to address our 
research question I defined a specific scope. Because covering all possible secondary 
uses of clinical data is a monumental endeavor, I limited our scope to uses where clinical 
data are reused to answer a specific research question. The set of all possible research 
questions that can be answered reusing clinical data is extremely large; therefore, it is 
necessary to sample the most representative cases.  I chose to cover the most common 
analysis types and clinical data types. This will ensure the coverage of the most common 
modalities of research and the most frequently used sections of repurposed EHR data 
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(i.e., the clinical data types).  The research question was: "What are the most common 
analyses and clinical data types used for secondary use of clinical data?" 
4.1.1 - Methods 
I used two data sources to establish a distribution of secondary analysis types and clinical 
data types used in clinical data reuse research. First, a systematic review by Song et al. 
(Song, Liu, Abromitis, & Schleyer, 2013) that summarized the secondary uses of dental 
care data in the literature. Dental EHR records present much overlap with general EHR 
so I was able to use these results as a starting point. Variables relevant to the dental 
healthcare were not included (e.g., caries activity and periodontics procedure data). I 
classified analyses by type and clinical variables used to describe the distribution. The 
article defined the clinical variable types. The analysis type categories were defined using 
a qualitative grounded theory approach. They were derived from the research questions 
reported for every analysis in the literature review. The resulting categories were 
outcomes and distribution descriptions, association detection, prevalence estimation, 
effect size (e.g., treatment effectiveness) and other. This gave me a preliminary idea of 
the most frequently used data and their intended use. Second, I reviewed data requests 
submitted to a CDW team. The requests were recoded as service tickets in a tracking 
system database for the informatics core of a major healthcare research institution and 
served to bridge the gap between dental data and EHR. I reviewed each request and 
extracted the required clinical data types as well as the intended secondary analysis type, 
when available. I used the same clinical data type categories as for the previous dataset 
adding clinical notes, which were often used in this dataset but missing in the review 
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article. The considered analysis types were prevalence estimation, distribution, method 
validation and other. A large portion of the requests dealt with electronic patient 
recruitment (i.e., search of patients corresponding to a specific profile in the EHR 
database for potential enrolment in a randomized controlled trial enrolment or clinical 
chart review). This category was added as a secondary use type. The frequency of each 
analysis and data type was then computed. To confirm the validity of the secondary 
analysis categories, a second biomedical informatician independently classified the dental 
data analyses from the systematic review and the data request tickets. I used this second 
classification to calculate an unweighted Cohen's Kappa measure of inter-observer 
reliability.  
4.1.2 - Results 
The review of secondary uses of dental data (Song et al., 2013) presented 60 publications. 
All were included in this review. Then, I reviewed 238 clinical data request tickets 
spanning 5 years. 106 requests were excluded because they were misclassified technical 
requests (68 items), lacked information on requested variables (22 items), were requests 
of data other than clinical data (13 items) or were duplicate requests (3 items).   
The distribution of analysis types was similar for both data sources (Figures 3 and 4). We 
found that Association studies, Distribution & Outcomes, Prevalence Estimation and 
Electronic Patient Recruitment analysis types covered 91.67% of the dental data research 
and 96.69% of ticket cases. The inter-observer reliability (i.e. Cohen's Kappa) for the 
purpose classification was respectively 0.869 and 0.968 for the dental secondary analyses 
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and the data request tickets respectively, which denotes a high level of agreement 
between observers and, in turn, a reliable classification. In terms of clinical data types, I 
also found similar proportions between the review paper and the data requests (Figures 5 
and 6). I found that Demographics, Diagnoses, Appointments, Medications, Labs, Vitals 
covered 90.14% of the dental secondary analyses and 96.18% of the clinical data requests 
tickets.  
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Figure 3 - Distribution of analysis types for dental data reuse analyses. Over 90% of the 
analyses are Distribution/Outcome, Association or Prevalence estimation analyses. 
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Figure 4 - Distribution of analysis types for clinical data request tickets. Over 90% of the 
analyses are Electronic Patient Recruitment, Prevalence Estimation or Distribution 
analyses. 
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Figure 5 - Distribution of clinical data types for dental data reuse analyses. Over 90% of 
the analyses use Demographics, Diagnoses, Appointments, Medications, Vitals and Labs. 
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Figure 6 - Distribution of clinical data types for clinical data request tickets. Over 90% of 
the analyses use Demographics, Diagnoses, Appointment, Medication, Labs and Vitals 
data.   
 
 
  
 
58 
4.1.3 - Discussion  
I was able to define a limited number of analysis types and clinical data types that would 
cover over 90% of secondary analyses of clinical data. However, this approach has three 
main limitations. First, I reviewed only two data sources. The first one was a literature 
review on dental EHRs. I was able to use this review as a viable initial analysis because 
dental EHRs have similar data structures to clinical EHRs. The second data source was a 
group of unstructured data requests that required qualitative analysis but provided a 
broader overview of the types of analyses done for a CDW beyond published analyses. 
Thus, the combination of these two data sources provides a reasonable basis to define the 
main categories of analysis types and clinical data types used in secondary uses of EHR 
data. Second, I did not cover all possible features that define secondary use application. 
However, clinical data types and analysis types are two critical aspects that define 
secondary use projects and can be generalized across applications. Third, the analysis 
types were generated using qualitative grounded theory methods from reviewing research 
questions. These categories may not be exhaustive but the data shows that they cover 
most cases, leaving only 3% of the analyses in the 'Other' category.  
4.1.4 Use-Case Development 
After identifying analysis and clinical data types that cover over 90% of secondary use 
cases, I developed a set of specific secondary use cases to cover all combinations of these 
types. I asked a clinical expert to define research questions serially as they came up in his 
research activities. I then developed those research questions into full-fledged use cases 
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by including all additional information on assumptions and research design. A short list 
of these research questions is presented below; a full description of the use cases can be 
found in appendix C. Tables 3 and 4 show the coverage of these use cases across 
secondary analysis types and clinical data types. 
1. Is the second BP measure statistically lower than the first BP measure taken within a 
visit? 
2. Are dual BP measurements provider-dependent? 
3. How do patient weight measurements vary  over time? 
4. Is prednisone exposure correlated with weight gain?  
5. Are HbA1C lab values correlated with BMI? 
6. Can we find patients with BMI>25 and age>21? 
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Table 3 - Secondary analysis type coverage by case. Columns show each case and their 
relevant analysis types.   
 
Table 4 - Clinical data type coverage by case. Columns show each case and their relevant 
clinical data types.  
 
1	 2	 3	 4	 5	 6	
Demographics		 	 	 	 	 	 	
Diagnoses	 	 	 	 	 	 	
Appointments	 	 	 	 	 	 	
Meds	 	 	 	 	 	 	
Labs	 	 	 	 	 	
Vitals	 	 	 	 	 		
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4.2 - Method 
A data analytics team conducted DQ assessments using DataGauge for the six previously 
described use cases. We developed the DQ requirements using the preliminary guidance 
(see Table 1) that took into account the DQ dimensions, data granularity levels and DQ 
testing approaches. The team was composed of three domain experts: a clinician, a 
statistician and a data scientist who also served as a database administrator. We first 
generated a data needs model iteratively for each case. The model was discussed 
collectively. At least two iterations were carried out for every case. Once the DNM was 
established for every research question, we led one-hour interviews with the clinician and 
statistician; the team’s data scientist led the interviews. The requirements were encoded 
from notes taken during each interview sessions. An approximate total of 20 hours was 
spent with each expert to generate the final list of requirements. The final DQ standards 
contained a list of DQ requirements for each case. The six final standards represented the 
list of minimum requirements for each dataset to be fit for purpose. 
Once all requirements were available for each case, I selected dimensions to define an 
overview. These dimensions were selected based on their ability to cover the DQ 
requirement generation problem space (i.e. the DQ theory, domain knowledge, assessed 
data, etc.). This overview would serve as a checklist to ensure that the team generating 
the DQ requirements would cover all relevant aspects. The dimensions were chosen to 
improve  DataGauge's current guidance (see section 3.2.3 for details) by (1) providing an 
overview of aspects to cover, (2) bridging the gap between the guidance and clinical 
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domain knowledge, while (3) supplying the analytics team with concrete questions to 
develop all relevant DQ requirements. 
For each sub-section of this overview we listed all relevant requirements and we 
generated questions to guide the generation of DQ requirements. These questions aim to 
help users to consider all potential flaws relevant to that specific section of the overview. 
Providing concrete issues to consider aims to support the generation of DQ requirements 
by focusing the expert's attention to known potential threats to fitness for purpose. 
Phrasing the guidance in the form of questions forces the analytics team to respond to 
specific queries and structure their search around specific interest points rather than 
searching a vast problem space. The overview helps the team have a clear idea of the 
extent to which potential issues have been covered. An example of the guidance is 
described in section 4.4, a full version of the guidance framework (i.e., overview 
checklist and question lists) is available in Appendix B.  
4.3 - Results 
4.3.1 - DQ Requirements Dataset Overview and Descriptive Statistics 
Our experts generated 389 requirements across the six cases. Figure 7 shows the 
distribution number of requirements by case. These requirements describe features a 
dataset must have to be fit for purpose.  
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Figure 7 - Distribution of DQ requirements by use case number. 
4.3.2 - Guidance Dimensions 
The final guidance included four dimensions (Table 5).  The two dimensions from the 
original DataGauge guidance were preserved. (1) The DQ dimensions as described in 
chapter 3 (i.e., correctness, plausibility, completeness, concordance, representation and 
timeliness) remained the link to DQ theory.  (2) The levels of data granularity (Borek et 
al., 2011) (i.e., single value, multiple values, observation, observational unit and dataset) 
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remained the primary link in the DNM and reduce complexity. I used these two initial 
dimensions to develop the DQ requirements for the six cases. Two new dimensions were 
added as the result of the team-based development work. (3) To address the lack of 
integration with domain knowledge, I defined a list of knowledge domains. These 
directly represent the different areas of expertise necessary to run a secondary use 
analysis project and could be mapped to the three expert roles by Barlow (Barlow, 2013). 
The clinical expert held knowledge about the clinical/medical science domain and the 
clinical workflow. The statistician held the knowledge about the analytical tools and the 
research design. The data scientist held the knowledge about data representation and 
data manipulation. I also defined an additional research goal knowledge domain 
common to all three experts that represents the research question and purpose-specific 
considerations. These knowledge domains and their limitations surfaced continuously 
during the expert interviews, revealing knowledge gaps between experts as well as the 
need for integrated expertise and teamwork. The knowledge domains dimension is useful 
to separate out the types of background knowledge to be thought of individually when 
generating DQ requirements and allowing to communicate with experts. This also 
grounds the DQ generation task by providing some structure. The knowledge domains 
dimension contributes to the separation of concerns (Painter, 2006) and contributes to a 
more orderly development of DQ requirements. (4) To further ground the guidance to 
make it less abstract, while bridging the gap between the evaluated datasets and the 
clinical knowledge domain, I defined the clinical data types dimension. I used the same 
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clinical data types from those defined in section 4.1 (i.e., demographics, appointments, 
diagnoses, prescriptions, lab results and vitals). 
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Table 5 - Overview of the four dimensions of our framework for DQ requirement 
guidance.  
 DQ 
Dimensions 
Levels of Data 
Granularity 
Knowledge 
Domains 
Clinical Data 
Types 
Aspects of 
DQ 
Assessments 
Represented 
DQ theory  DNM 
integration and 
dissection 
Overarching 
expertise needs, 
Domain 
knowledge, 
Multi-
disciplinary 
approach  
Data model of 
origin, Data 
production 
considerations, 
Clinical domain 
knowledge 
Elements Correctness, 
Plausibility, 
Completeness, 
Concordance, 
Representation, 
Timeliness 
Single value, 
Variable, 
Observation, 
Observational 
Unit,  
Multiple 
Observational 
Units,  
Dataset 
Analytical Tool,  
Clinical, 
Data 
Manipulation, 
Representation,  
Research Design, 
Research Goal,  
Workflow 
Demographics, 
Appointments, 
Diagnoses,  
Vitals, 
Prescriptions,  
Lab results 
 
Guidance 
Need 
Addressed 
-Connection to 
DQ theory 
 
-Provides a way 
to break down 
the complexity 
of datasets 
-Provides a way 
to examine the 
dataset as a 
series of 
subsets 
-Provides an 
overview of 
relevant areas of 
expertise 
-Creates a link to 
domain 
knowledge  
-Separates 
concerns (Painter, 
2006) when 
developing DQ 
requirements 
-Reduces 
vagueness and 
abstraction  
-Provides a link 
to the assessed 
data and the 
clinical domain 
knowledge 
Source Work DQ Dimensions 
(Wang & 
Strong, 1996) 
adapted the 
secondary use 
(Nicole Gray 
Weiskopf & 
Weng, 2013), 
modified in 
Chapter 3 
Classification 
of DQ testing 
approaches 
(Borek et al., 
2011; Oliveira 
et al., 2005), 
adapted in 
Chapter 3 
Expert interviews 
(see Section 4.2) 
as an extension of 
the areas 
expertise needed 
to carry out 
secondary 
analyses of data 
(Barlow, 2013) 
Clinical data 
reuse case 
definition (see 
Section 4.1), 
partially based on 
(Song et al., 
2013) 
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4.3.3 - Overview Dimensions and DQ Requirement Generation Contexts 
Providing an overview of DQ requirement generation activities is one goals of this new 
guidance framework. The utility of an overview is to provide the research team with a list 
of aspects to consider when generating the DQ requirements. The knowledge domain 
dimension is most fit to serve as a base to build the the framework for four reasons: (1) It 
represents the expertise held by the team as a whole, (2) It can be used to allocate 
responsibility and separate concerns during the DQ requirement generation (Painter, 
2006), (3) Domain knowledge is necessary to carry out every step of the DQ assessment 
process and (4) It is the most encompassing and comprehensive dimension.  
To identify another dimension that could be included in the overview, I checked whether 
the knowledge domain dimension could be paired with any of the other three dimensions. 
The goal was to identify a combination that would create separation of concerns (Painter, 
2006), while giving a comprehensive overview of the problem space. Ideally, the 
combined dimensions would allow DQ requirement generation for every dimension 
element combinations (e.g., clinical knowledge and the completeness DQ dimension). I 
examined this by creating heat maps the number of DQ requirements generated from the 
six use cases for combinations of the knowledge domains and other three dimensions 
(Figures 8-9). I found that the generated DQ requirements fully covered the combination 
of Knowledge Domains and Clinical Data Types (Figure 9). This means that for every 
combination of knowledge domain and clinical data type elements it is possible to 
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generate DQ requirements. I refer to the combination of a knowledge domain element 
(e.g., clinical domain) and a clinical data type (e.g., vitals) as a DQ requirement 
generation context. To emphasize the need to cover each DQ requirement generation 
context I converted Figure 9 into a checklist (Table 6). This checklist gives the analytics 
team a clear list of all possible DQ generation contexts; each context corresponds to a 
checkbox. This overview should help the analytics team to clearly keep track of the 
contexts covered during the design of the DQ assessment.  
 
Figure 8 - Distribution of DQ requirements by DQ dimensions and knowledge domain. 
The generated requirements fail to cover all sub-sections of this two-dimensional space.  
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Figure 9 - Distribution of DQ requirements by data granularity levels and knowledge 
domain. The generated requirements fail to cover all sub-sections of this two-dimensional 
space.  
 
Figure 10 - Distribution of DQ requirements by clinical data type and knowledge 
domain. The generated requirements cover each sub-section of this two-dimensional 
space. This makes these two dimensions useful to define a comprehensive problem-
space.  
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Table 6 - Overview guidance checklist for DQ requirement development. This checklist 
partitions the problem-space of DQ requirement development into sub-sections or DQ 
generation contexts defined by the knowledge domain (left column) and the clinical data 
type (top row). This partitioning provides the analytics team with a clear idea of the 
aspects to cover and breaks the complexity of DQ requirement generation into 
manageable sub-tasks. 
	 Vitals	 Demographics	 Meds	 Appointment	 Labs	 Diagnoses	
Clinical	 þ	 ☐	 ☐	 ☐	 ☐	 ☐	
Analytical	Tool	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Data	Manipulation	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Representation	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Research	Design	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Research	Goal	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Workflow	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
 
4.3.4 - Contextual DQ Requirement Generation  
The two remaining dimensions (i.e., DQ dimensions and levels of data granularity) were 
allocated to provide guidance within each DQ requirement generation context (i.e., the 
combination of a knowledge domain and a clinical data type). I provide two sources of 
guidance: (1) the original guidance that combines the DQ dimensions and levels of data 
granularity as well as (2) a series of context-specific questions generated from the DQ 
requirements available from the six use cases. The original guidance provided by the 
DataGauge framework (see section 3.2.3) is used to break down the DNM into simpler 
data structure at every data granularity level.  
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To provide more specific and domain-appropriate guidance, I formulated guidance 
questions from the DQ requirements generated for the six use cases for each specific DQ 
requirement development context. The role of these questions is to direct the analytics 
team's attention to specific threats to fitness for purpose. I classified the questions 
according to the evaluated DQ dimensions. Table 7 shows a sample of these of questions 
for the clinical knowledge domain and the “Vitals” clinical data type. All levels of 
granularity are relevant to all questions if they are represented in the DNM. The data 
granularity levels are involved in the process by aiding the DNM decomposition into a 
list of pieces for which the domain expert will answer the questions. In the next section I 
present an example of the use of this guidance for the development of DQ requirements.  
Table 7 - Sample of DQ requirement development guidance questions. These questions 
aim to guide the analytics team to address general DQ issues that may be a threat to 
fitness for purpose. The team will define DQ requirements based on these questions 
taking into account the assessed data and the research question. The resulting 
requirements define the features of a dataset that would be fit for purpose. An example of 
their use is shown in the following section.  
DQ	Dimension	 Guidance	Question	
Completeness	 Are	there	enough	values	to	carry	out	the	analysis?	
Completeness	 Are	all	expected	vital	values	present?		
Completeness	 Are	there	any	missing	values	for	each	vital	record?		
Correctness	 Are	the	values	within	the	clinically	expected	range?	
Plausibility	 Are	all	measurements	taken	after	the	patient's	
date	of	birth?		
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4.4 - DQ Requirement Definition Guidance Example 
Within DataGauge, DQ requirements are generated after the research question and the 
DNM are defined (see Chapter 3). The DNM defines the relevant clinical data types; all 
knowledge domains should be considered for every research question. For this example, I 
use the same research question used in Chapter 3: " Is prednisone, a commonly-
prescribed corticosteroid, associated with weight gain?"  The associated DNM model is 
shown in Figure 11. The relevant data types for this specific DNM are Demographics, 
represented by the Patient table, Medications, represented by the PrednisonePrescription 
table and Vitals, represented by the Weights table. As stated earlier, all knowledge 
domains are relevant. The relevant guidance checklist and overview is shown in Table 8. 
 
Figure 11 - Data Needs Model for the research question " Is prednisone, a commonly-
prescribed corticosteroid, is associated with weight gain?"   
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Table 8 - Overview guidance checklist for the research question " Is prednisone, a 
commonly-prescribed corticosteroid, is associated with weight gain?"  Clinical data types 
are eliminated based on their relevance. In this case, Appointments, Labs and Diagnoses 
were not relevant.  
	 Vitals	 Demographics	 Meds	
Clinical	 ☐	 ☐	 ☐	
Analytical	Tool	 ☐	 ☐	 ☐	
Data	Manipulation	 ☐	 ☐	 ☐	
Representation	 ☐	 ☐	 ☐	
Research	Design	 ☐	 ☐	 ☐	
Research	Goal	 ☐	 ☐	 ☐	
Workflow	 ☐	 ☐	 ☐	
 
For a relevant data type, the research team selects a specific knowledge domain and the 
questions relevant to that context (i.e., the combination of a clinical data type and 
knowledge domain) are retrieved. For our example, we first select the Vitals clinical data 
type and the clinical knowledge domain (i.e., the top left checkbox on Table 8). The team 
then selects portions of the DNM relevant to the assessed clinical data type. For our 
example, the relevant data elements are: the values within the Timestamp, Value and 
PatientID variables, these three variables themselves, each observation containing a 
combination of Value, Timestamp and PatientID, the Weight table, the combination of 
the patient and Weight tables and the whole dataset containing information about vitals, 
patients and prescriptions. With this information available, we can then proceed to 
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answer the contextual guidance questions for each element of this list. The list of relevant 
questions for this requirement generation context is shown on Table 9.  
 
Table 9 - Contextual guidance questions relevant to the clinical domain knowledge and 
the Vitals clinical data type. This is the full list of questions available for this context 
(i.e., top left check box on Table 7). The full list of questions for the other contexts is 
available in Appendix B.  
DQ Dimension 
Addressed 
DQ Generation Guidance Question 
Completeness Are all expected vital values present? 
Completeness Are there any missing values for each vital record? 
Completeness Do related values have a match? (e.g., systolic + diastolic 
blood pressure) 
Completeness Is the numeric distribution of values and value frequencies 
as expected? 
Correctness Are all values within plausible limits for the population? 
Completeness Are there an adequate number of measurements within the 
desired observation window? 
Correctness Are the measurements taken after the patient's date of 
birth? 
Completeness Are there sufficient values over time for the analysis? 
Completeness Is the number of vital measurements as expected? (e.g., at 
least one weight measurement per visit) 
Correctness Is the difference in consecutive values in an encounter 
within acceptable range? 
Correctness Is the difference between variable values between two time 
points in acceptable proportion? 
Plausibility Are time stamps in the expected order? (e.g., order before 
admin) 
Plausibility Are time stamps within the expected time frame? (e.g., 
BPs measured within the encounter window vs. outside). 
Timeliness Is the time between events of the expected range? 
Concordance Are there any sudden changes over time? Are they valid? 
Concordance Are the values coherent or vary as expected within a visit? 
Concordance Is the overall vital measure variability as expected? 
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The combination of a question and the data granularity level DNM pieces (e.g., a weight 
value, the weight variable or a weight observation which combines a weight value, a 
timestamp and patient ID) may generate one or multiple DQ requirements. For each 
question, the expert must consider the research question to inform the definition of 
requirements for a fit-for-purpose dataset. For example, when the clinical expert 
considers the question "Are all expected vital values present?", which addresses the 
completeness DQ dimension, and we are evaluating the weight values, which is a 
considered part of the “Vitals” data type, the team may generate requirements such as 
"There are adult patients with weights between 50 and 100kg". This is purpose-specific 
because the research question (i.e., "Is prednisone, a commonly-prescribed corticosteroid, 
is associated with weight gain?") is likely to be answered using adult patient data, given 
that children weights increase over time and the prednisone effect may be masked. At the 
observation level (i.e., the combination of a weight value, a timestamp and a patientID), 
the expert may come up with "All weight values have a timestamp value", which is 
necessary to calculate the rate of weight gain to answer the research question.  
When considering the guidance question "Are there sufficient values over time for the 
analysis?” which addresses the DQ dimension of timeliness, for the timestamp variable 
within this same context, the expert may come up with requirements such as "Patients 
have at least one weight per encounter" to ensure there is no censoring, "Patients have at 
least two weights overall" to be able to calculate the rate of weight change, "Patient has at 
least one weight per year between the first and last visit" to ensure reasonable temporal 
resolution. When considering the whole dataset, the expert may come up with a 
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requirement such as "Patient has at least two measurements within a year of the first 
prednisone prescription" to ensure that there is enough data in the timeframe where the 
effect is expected.  
When considering the question "Are there any sudden changes over time?", which 
considers the dimension of concordance, the experts may come up with requirements 
such as "Weight within a day should not vary more than X%", "Weights may not vary 
more than X% per month" and "Weights may not vary more than X% overall", which 
would reveal potentially inaccurate values that may distort relationship value found in the 
analysis.  
The team will run through the whole list of questions for that specific checkbox and then 
move on to the next knowledge domain. When all knowledge domains are covered, the 
team moves on to the next relevant clinical data type and repeats the procedure. Once all 
clinical data types are reviewed, all checkboxes should be marked. All generated 
requirements are aggregated into the DQ standard, which is specific to the research 
question and the DNM in question. These requirements define the DQ tests that will yield 
the DQ measures to evaluate fitness for purpose within the DataGauge framework.  
4.4 - Conclusion 
In this chapter, I presented a framework to support the development of DQ requirements 
for a specific research question and DNM within DataGauge. The framework addresses 
the shortcomings of current guidance available in the literature and the DataGauge 
process to enable the systematic generation of DQ requirements. The framework provides 
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(1) A clear overview of the issues to be considered while developing DQ requirements 
for a specific dataset and research question, (2) A bridge between domain knowledge and 
the DQ requirement generation task and (3) A list of specific issues and threats to be 
considered in the form of questions.   
This framework provides support to the user by providing an overview of the main points 
to be considered when assessing DQ. This provides an overarching frame to pose 
questions about the appropriateness of a given dataset for a specific purpose. Because of 
its dimensions, it supports the separation of concerns (Painter, 2006), which is likely to 
provide a more organized and thorough DQ requirement generation. This framework also 
addresses the gap between the evaluated data, the domain knowledge and the DQ theory 
stated in the literature (Floridi, 2013) and provides an overarching map to ensure 
systematic coverage of all concerns. Finally, this framework supports the systematic 
definition of DQ requirements. This step is critical because a DQ assessment is the 
combination of DQ tests that are directly defined by the DQ requirements. Thus, the 
thoroughness of the DQ assessment is directly dependent on the thorough definition of 
DQ requirements.  
This framework provides an unambiguous checklist and overview to check for issues as a 
way to ensure coverage and systematicity. It also provides specific questions as a way to 
focus the generation of DQ requirements on specific threats to fitness for purpose. 
However, this is an initial framework that does not cover all possible clinical data types 
and was developed based on a limited number of cases. Nevertheless, our cases cover the 
most broadly used data types and secondary use applications (see section 4.2). A single 
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analytics team was involved in the framework's development because we aimed to 
develop this initial framework that will be further expanded as other research groups 
adopt DataGauge.  The guidance checklist provides a development base that is applicable 
to other projects as a launching point for future development. Finally, the current version 
of the guidance questions may not be phrased in the ideal way. Thus, validation and 
further refinement is still necessary and will be part of our future research. This work will 
be carried out after the initial DataGauge evaluation described in the following chapter.  
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Chapter 5: Evaluation of DataGauge 
This chapter presents an evaluation of DataGauge's ability to improve upon the current 
state of the art methods of systematic DQ assessment. My hypothesis is that DataGauge 
will increase the number of DQ issues flagged for a specific secondary use of clinical 
data over the current systematic state of the art method. This evaluation will test 
DataGauge's potential usefulness, inform future research directions and identify further 
development routes. One particularly interesting aspect in this evaluation is that 
DataGauge is one of the first systematic DQ assessment methods to allow a systematic, 
fitness-for-purpose approach to the assessment of repurposed clinical data. This sort of 
approach has been advocated as the preferred method for DQ assessment in the field of 
clinical informatics (Holve et al., 2013), yet a viable candidate is still missing.  
Comparing the performance of DataGauge against a general DQ assessment method 
would also provide evidence to evaluate the advantage, if any, of a fit for purpose 
approach versus a generic one.  
In this chapter I describe the process carried out to evaluate DataGauge against a state of 
the art DQ assessment method (i.e., the evaluation standard). First, I describe the methods 
used for the evaluation, including the rationale for the evaluation standard selection. Then 
I present and compare the performance results for DataGauge and the evaluation standard 
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over the six cases defined in section 4.2. Finally, I discuss these results and their 
implications. 
5.1 - Methods 
5.1.1 - Defining a DQ Assessment Standard 
To evaluate the performance of our assessment method it is necessary to select a control 
or baseline method. In most analyses carried out for research purposes some kind of data 
cleaning procedure (Broeck & Fadnes, 2013) is carried out by the analyst. This consists 
of detecting, diagnosing and rectifying anomalies in the dataset as the analysis 
progresses. The main pitfall of this approach is that, being analyst-dependent; there is a 
risk of missing errors that threaten the assessment's thoroughness. This is especially 
problematic when the data in question are repurposed because an additional set of 
complex issues come into play (Hersh et al., 2013; Van Der Lei, 1991). In fact, data 
cleaning is geared towards cleaning datasets produced and used for the same purpose 
such as randomized controlled trial datasets (Van den Broeck et al., 2005) rather than 
repurposed data. An additional pitfall is that, because cleaning happens in parallel to the 
analysis, the analyst may find "satisfactory" results from flawed data on first approach 
and never question their accuracy. Thus, data cleaning is unlikely to be a reliable 
comparison standard.  
Though many individual tools are available to test discrete aspects of DQ (Borek et al., 
2011), very few tools are available to carry out whole DQ assessments. However, an 
automated tool to assess the DQ in the initial phase of integrating EHR data into a CDW 
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is currently available. The Automated Characterization of Health Information at Large-
scale Longitudinal Evidence Systems (ACHILLES) (G Hripcsak et al., 2015) is a 
platform, which enables the characterization, quality assessment and visualization of 
observational health databases. ACHILLES was released by the Observational Health 
Data Sciences and Informatics (OHDSI) collaborative and provides a module called 
ACHILLES Heel (G Hripcsak et al., 2015) that allows the user to automatically detect 
database integrity issues and DQ flaws in clinical datasets modelled using the OMOP 
common data model (Overhage, Ryan, Reich, Hartzema, & Stang, 2012; Reisinger et al., 
2010). ACHILLES is a state-of-the-art tool to automatically assess DQ in CDWs. It is 
capable of detecting issues such as predefined value compliance, limited numeric value 
range checks, temporal inconsistencies and data model integrity checks (e.g., primary key 
and foreign key check).  
Because ACHILLES is an automated, code-based tool, it is capable of consistently 
testing all relevant DQ aspects that an expert user with knowledge of the database would 
run. This sort of consistency is desirable for a comparison standard or baseline because 
the end output would be the same no matter how many tests are run as long as the tested 
database remains unchanged.  Another virtue of ACHILLES is that, by design, it does not 
consider the research question or analytical purpose. One of the limitations of 
ACHILLES is that, in its current version, it does not check for statistical outliers. 
Statisticians and data analysts routinely use the following rule for outlier detection: 
values outside three standard deviations to each side of the mean are considered probable 
outliers in normally-distributed data; the range grows to five standard deviations for any 
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other kind of distribution (Amidan, Ferryman, & Cooley, 2005; Rahbar et al., 2013). To 
address this shortcoming, I supplemented ACHILLES with this outlier detection function. 
The final standard of comparison selected for evaluation was the ACHILLES module 
supplemented by the statistical outlier detection rule described above. 
5.1.2 - Testing Protocol 
My test dataset consisted of a teaching outpatient clinic's EHR's database from a major 
metropolitan area. This dataset contained 10 years of data for 954,891 patients. The EHR 
database was restructured to comply with the Observational Medical Outcomes 
Partnership (OMOP) Common Data Model (CDM) Version 5 (G Hripcsak et al., 2015; 
Overhage et al., 2012). This enabled me to run the ACHILLES module automatically.  
For each test case, I created a new database containing only the data relevant to the 
research question. This allowed a complete, yet focused ACHILLES assessment of the 
whole database where only issues relevant to the appropriate data would be flagged. 
ACHILLES ran automatically on the filtered datasets.  To run DataGauge, I coded SQL-
based query tests for each requirement generated by experts in the previous experiment 
(see Section 4.2 for detailed methods). Each query, I counted the number of violations in 
the dataset for the requirement it tested. Each violation flag represented a potential DQ 
issue. These counts are the DQ assessment results or DQ measures that quantify the 
dataset's adherence to the DQ requirements defined using DataGauge.  
Both methods flag requirement violations that could ultimately be a threat to the validity 
of analytical results. On one hand, the comparison standard focuses on identifying 
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general integrity issues in the dataset. The issues found can be of two kinds: (1) they 
could affect the intended use and become a significant data problem or (2) they may not 
threaten the purpose directly. These indirect threats are issues that do not jeopardize 
answering the research question but may distort the answer if they are too prevalent. On 
the other hand, the requirements generated by experts using DataGauge requirements 
describe a fit-for-purpose dataset. Therefore, each violation is a potential threat to the 
secondary analysis because they represent a shortcoming of the assessed dataset in 
relation to the ideal dataset. However, not all requirements represent the same level of 
threat to fitness for purpose. To quantify the level of threat, we asked the analytics team 
generating the requirements to assign a value to the issue in one of two categories: (1) 
Discarding Requirements, which reveal a direct threats to fitness for purpose (e.g., Patient 
records that infringe on the requirement "Patient has at least two weight measurements" 
for the calculation of weight change over time); (2) Review Requirements, which indicate 
a potential flaw that may be rectified via imputation methods or are not a direct threat to 
the dataset's fitness for secondary use (e.g., Breaches of "Weight values don't change 
more than 2% within a day" should be reviewed and may be potentially corrected using 
imputation methods if there are enough values to provide a stable baseline). Each DQ test 
from DataGauge had such value assigned during the initial generation. The same 
classification process was done for the evaluation standard results for each case.  
5.1.3 - Major Differences in DQ Assessment Methods 
There are three major differences between the DQ assessment tools that must be taken 
into account when interpreting the results. First, the knowledge available when 
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generating the test code for each method is different. The evaluation standard (i.e., 
ACHILLES + Outlier detection) is an automated method designed to be broadly 
applicable and only taps into knowledge about the data structure. On the other hand, this 
standard is easier to use, requiring minimal human effort and involvement because it is 
based on executable code. This makes its results reproducible, as they are not based on 
human expertise.  In contrast, DataGauge benefits from a team of experts and their 
knowledge about the data source, the purpose and domain knowledge. This means that 
the DQ tests performed by DataGauge should be much more specific and purposeful than 
those done by ACHILLES. Second, DataGauge is designed to be purpose-specific, 
whereas the standard does not take the purpose into account by design. Therefore, the 
issues flagged by the standard may not be a threat to the purpose. To address this, the 
issues found by both methods were assigned a level of threat value: discarding 
requirements (i.e., direct threats to fitness for purpose) or review requirements (i.e., 
potential flaws that may be rectified via imputation methods or are not a direct threat to 
fitness for secondary use). Finally, it is important to note that our comparison standard is 
static executable code, whereas DataGauge is based on a set of requirements generated by 
a team of experts. This means that the issues flagged by DataGauge are extremely likely 
to be relevant threats to the fitness for purpose of the dataset by design (given that each 
assessment is tailored to each research question and dataset's needs), whereas the 
comparison standard flags issues that are likely to be data flaws without taking the 
purpose into account. Therefore, it is necessary to review the issues found by the standard 
to confirm their relevancy to assessing fitness for purpose. 
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5.2 - Results 
I compared the results in three ways. First, I compared the number of issues found by 
each method. I show overall performance in flagging potential DQ issues for each 
method, followed by a breakdown by DQ requirement severity based on the 
requirement's level of threat to fitness for purpose (i.e., discarding vs. review 
requirement). I then reviewed the most common DQ issues flagged by both methods to 
confirm that the issues found were true DQ issues. Second, I compared the coverage of 
each method based on the previously-defined overview dimensions (i.e., clinical data 
types and the knowledge domains -see section 4.1) derived from EHR database design 
features and types of expertise required for a data reuse project (Barlow, 2013). This 
shows the comprehensiveness of each method. Finally, I built a regression model to 
predict the number of flags found by each method. I counted the total number of tests 
carried out by each method and the total number of tests flagged as positive. I used these 
two variables for each method to build a negative binomial to predict the number of 
issues found based on the selected methods and the number of test instances. Each case 
was considered a separate experiment. All analyses were conducted using R Version 
3.2.2 (R Core Team, 2013) assuming statistical significance at p<0·05.  
5.2.1 - Number of Flags  
Data Gauge flagged roughly ten times more issues than the comparison standard. These 
issues represent individual data elements that infringed on a DQ requirement. Overall, the 
standard returned 1.4 million flags whereas DataGauge returned 19 million (Figure 12). 
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Review flag counts were 1 million flags from the comparison standard versus 9.3 million 
for DataGauge (Figure 13). Discarding flag counts showed, 0.4 million for the standard 
versus 9.6 million for DataGauge (Figure 13).  
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Figure 12 - Number of flags returned by both methods. DataGauge returned close to ten 
times more flags than the comparison standard.  
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Figure 13 - Number of discarding and review flags returned by both methods. 
DataGauge returned close to ten times more review flags than the comparison standard 
(left) and close to twenty times more discarding flags (right). 
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Reviewing the most common flags revealed multiple overlaps, yet DataGauge included 
all flags found by the standard plus more specific issues. Dataset integrity issues were 
found by both methods. For example, the control method flagged person, provider and 
care site IDs with no correspondence in the table that contained the variables that defined 
them (e.g., the demographics table for patients); DataGauge identified the same issues as 
primary key-foreign key relationship breaches. Data values were checked by both 
methods but DataGauge did this in a more purposeful way. More specifically, the control 
method checked for statistical outliers, which provides a knowledge-independent and 
broadly applicable way of screening for outliers. These outliers are extremely likely to be 
true outliers but the results provide no insight to determine the nature of the DQ issues. 
On the other hand, DataGauge flagged values for specific reasons such as vital values out 
of range (e.g., Weight measurements over 400kg that are possible but not likely), abrupt 
changes over time (e.g., weight changes larger than 10% in the same day) and impossible 
timelines (e.g., measurement taken before the patient's date of birth). Beyond these two 
categories, DataGauge identified issues that were specific threats to the fitness for 
purpose that the control method was unable to flag. For example, patients with 
overlapping or co-occurring prescriptions for a research question dealing with drug 
exposure and weight variation; the threat to the secondary analysis is that we are unable 
to confidently calculate the effective drug exposure because the uncertainty in the drug 
exposure timeframe.  
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Examining the most common issues for review and discarding requirements confirmed 
the drastic difference in test specificity. This confirmed the value of purpose-specific 
tests in providing data to evaluate fitness for purpose; review flags clearly showed this 
difference. For example, the control method found unidentifiable providers and care sites, 
which were marginally threatening to the purpose in most cases, whereas DataGauge 
found direct threats to the purpose such as missing covariate data and unexpectedly high 
value changes over time. Discarding requirements showed the same differences. The 
control method flagged statistical outliers and person IDs that could not be mapped to the 
demographics table rendering the record in question unusable. In contrast, DataGauge 
found patients without the necessary data to conduct the primary analysis (excluding 
covariates), data outside the plausible timeframe, prescriptions with missing values that 
prevented the calculation of an effective dose, amongst other issues.  
5.2.2 - Coverage of Clinical Data Types and Knowledge Domains 
Dimension coverage revealed great differences between methods. DataGauge found 
issues in all Clinical Data Types (Figure 14) and Knowledge domains (Figure 15). On the 
other hand, the comparison standard failed to identify any issues in two out of six clinical 
data types and three out of six knowledge domains. The overview also shows a larger 
number of flags on the DataGauge side for every category where both methods returned 
flags. 
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Figure 14 - Coverage of clinical data types by the control method and DataGauge. 
DataGauge covers all clinical data types, whereas the comparison standard fails to flag 
any issues for diagnoses and labs. DataGauge also flags more issues for in all data types 
covered by both methods. 
 
Figure 15 - Coverage of knowledge domains by the comparison standard and 
DataGauge. DataGauge covers all knowledge domains, whereas the comparison fails to 
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flag any issues in three domains. DataGauge also flags more issues in all domains 
covered by both methods. 
 
5.2.3 - Statistical Comparison 
Statistical comparison of both methods revealed a statistically significant difference 
between the two methods when comparing values for only six cases. I compare the 
number of issues flagged between DataGauge and the evaluation standard using negative 
binomial regression model that accounts for the over-dispersed count data, using the total 
number of tests done by each method as an offset variable (Table 10). To account for 
potential confounding effects, I compare matched DQ assessment results for a series of 
cases (i.e., six matching research question and dataset pairs), where only the applied 
method varies. I also explored covariates such as data granularity, analytical unit and DQ 
dimension but none of them  significantly impacted the estimates of interest . The 
expected number of flags returned by DataGauge was significantly higher than the 
number returned by standard (Rate Ratio=7.00; 95% CI=[3.22,15.2]; p<0.0001).   
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Table 10 – Comparison of the number of flags returned by each method based on 
multivariable Negative Binomial regression model . The expected number of flags 
returned by DataGauge is almost seven times greater than the number returned by the 
control method. 
 
Rate Ratio (95% 
Confidence Interval) 
p-value 
Method 7.00 (3.22,15.2) <0.0001 
 
5.3 Discussion 
DataGauge was able to flag more potential issues than the state of the art method. It 
identified more direct threats to the analytical purpose, but also more DQ issues that 
could be potentially corrected via review or imputation. This difference was confirmed to 
be statistically significant. The issues identified by DataGauge were also more specific, 
which allowed for a deeper understanding the dataset's limitations. Finally, DataGauge 
showed broader coverage of Knowledge Domains and Clinical Data Types. 
This analysis provides evidence of DataGauge's contribution to the current state of the art 
but has three main limitations. First, we only used a single clinical database containing 
outpatient data. Though this is only one type of clinical data, but is one of the most 
broadly available for secondary use. Second, we only assessed DQ for six use cases. 
However, we justified their coverage of secondary uses and clinical data types in Chapter 
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4. Moreover, these six cases provided adequate statistical power to uncover a statistically 
significant difference between DataGauge and the comparison standard. Third, only one 
research team was employed in this evaluation, thus the results may not generalize.  
Based on these results, I can conclude that DataGauge improves the current state of the 
art by improving the detection of DQ issues in two ways. First, DataGauge increases the 
number of opportunities to detect DQ issues by providing a broader coverage of the 
assessed data and relevant knowledge domains. Second, DataGauge focuses the detection 
of specific issues that are directly relevant to the intended secondary use. DataGauge is 
the first systematic method to assess DQ in truly fitness-for-purpose-oriented way (Holve 
et al., 2013; Juran, 1962). Even though the method is human intensive, the great threats 
posed by data repurposing (Hersh et al., 2013; Van Der Lei, 1991) demand such thorough 
evaluation. Also, it is currently very difficult to truly assess fitness for purpose in an 
automated way given that it requires so much domain knowledge that is not readily 
structured. Nevertheless, DataGauge provides an initial systematic process that can 
support future automation efforts.  Also, when applied thoroughly by a team of experts, 
DataGauge is more likely that the current systematic methods to provide a useful body of 
evidence to justify or reject the use of a data source for a specific secondary use. 
This evaluation provides evidence to confirm that DataGauge improves the current state 
of the art. DataGauge builds upon Kahn's framework for pragmatic DQ assessment 
framework (M. G. Kahn et al., 2012). It provides practical implementation support for a 
previously unavailable fitness for purpose DQ assessment of repurposed clinical datasets 
(Holve et al., 2013). It also provides methodological grounding for the implementation of 
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the recently published the ontology for the secondary use of clinical data (Johnson et al., 
2015).  
These results also encourage the use of fitness for purpose approaches for DQ assessment 
of repurposed clinical datasets (Holve et al., 2013) because of their ability to find specific 
issues that will encourage or discourage the use of a dataset for a specific purpose. 
Though these results are encouraging, a deeper evaluation of the method's usefulness and 
utility to real analytics teams is necessary. In this preliminary evaluation I employed 
automated methods as a starting point of comparison. However, research teams making 
secondary use of data usually carry out additional ad hoc tests and custom data cleaning. 
This limitation will be addressed in a future work.  
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Chapter 6: Conclusions, Limitations and Contributions 
In this dissertation, I have described and evaluated DataGauge, the first systematic yet 
purpose-specific procedure for the DQ assessment of repurposed clinical data. 
DataGauge addresses current limitations in the state of the art of DQ assessments. It 
provides a generalized and systematic way of assessing repurposed clinical data taking 
into account the research question for the secondary analysis. Additionally, it makes DQ 
assessment parameters explicit, supporting communication within the analytics team and 
the transparent reporting of clinical data. I also presented a framework for the 
development of DQ requirements within DataGauge, which lists the major concerns to be 
checked when repurposing clinical data to promote thorough assessments. This 
framework aims to promote comprehensiveness and separation of concerns (Painter, 
2006) when designing DQ assessments, which contributes to a thorough and orderly 
development of DQ requirements when applying DataGauge. Finally, I evaluated the 
DataGauge process comparing it to a current state of the art systematic DQ assessment 
method. DataGauge flagged more issues than the evaluation standard, uncovering bigger 
threats to fitness for purpose and covering more aspects of the assessed data and 
knowledge domains. 
DataGauge improves the state of the art by supporting the systematic design and 
implementation of DQ assessments taking into account the secondary use purpose or 
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research question. Previous DQ assessment methods for the reuse of clinical data have 
focused on the application of multiple DQ tools to uncover discrete problems (e.g., typos, 
missing values, outliers) (Batini & Scannapieca, 2006b; Maydanchik, 2007a) and have 
failed to take the analytical purpose into account. Faulconer and de Lusignan (Faulconer 
& de Lusignan, 2004), for example, proposed a statistical procedure to identify DQ 
problems generically using mathematical tools rather than assessing potential threats to 
achieving the analytical purpose. Hogan and Wagner (Hogan & Wagner, 1997) also 
suggested statistical probes to identify specific data issues, but only addressed correctness 
and completeness. Kahn et al. (M. G. Kahn et al., 2012) proposed a purpose-based DQ 
assessment framework for the reuse of clinical data. However, this framework focuses on 
detecting DQ flaws based the data's primary clinical purpose rather than taking analysis-
specific considerations into account. Johnson et al. (Johnson et al., 2015) have proposed 
an ontology to make DQ measure calculations systematic, but do not provide a way to 
select these measures systematically to assess fitness for purpose. Thus, DataGauge is the 
first method to address the problem of analysis-specific DQ assessments.  
DataGauge is designed to be general enough to support a team of experts to 
systematically design and carry out their DQ assessment for any data source and 
analytical purpose. However, the development of DQ requirements across analytics teams 
is a potential source of inconsistencies.  To address this limitation, we have provided a 
framework to support the systematic development of DQ standards. We achieve this by 
providing a list of potential DQ issues to consider when repurposing clinical data. This 
guidance framework is a first step towards supporting the systematic definition of DQ 
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requirements. Further development and testing of this framework will be part of my 
future work.  
The definition of this method and evaluation results have multiple implications. For 
clinicians and researchers making secondary use of clinical data, DataGauge 
assessments allows for a more trustworthy repurposing of clinical data, by supporting 
thorough and purpose-specific assessments before the secondary analysis takes place. 
DataGauge also supports the reporting of DQ results by making the DQ assessment 
assumptions explicit, and therefore easier to report. DataGauge also promotes a more 
thorough assessment of repurposed clinical data because it accounts for the research 
question (i.e., the use purpose). This should lead to a better understanding of the 
limitations of repurposed clinical data and, in turn, the analytical results. Informaticians 
will benefit from this work by having a systematic way of assessing the quality of clinical 
data that is fully integrated with the data extraction process. DataGauge offers a 
streamlined way of integrating multiple workflows into a single process. This means that 
the work of the analytics team making secondary use of clinical data, the CDW team 
running the data extraction and the DQ assessment work are harmonized into a single 
workflow. The process is also supported by a set of documents that make assumptions 
explicit and may improve communication within and beyond the analytics team. 
DataGauge may also support the development of design tools and interfaces for 
secondary use and data extraction. Such tools are currently available but provide little to 
no support for DQ assessment.  
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6.1 - Limitations 
While DataGauge was shown to flag more potential DQ issues than the current state of 
the art method, there are a number of limitations to this work. The DataGauge process 
presents four main limitations. First, we do not provide guidance in terms of the number 
of iterations to reach satisfactory specifications as this depends on multiple factors such 
as analysis type, data needs and research goals. This must, therefore, be left to expert 
judgment. Second, DataGauge is tailored to support analysis-specific DQ assessments 
and therefore, assumes that the input dataset has been a pre-cleaned to meet the DQ 
standards expected from a CDW. Third, DataGauge is human-intensive because the 
exhaustive definition of DQ requirements and their testing require considerable effort. 
Also, in its current state, DataGauge requires custom coding for the testing of every DQ 
requirement, which is much more time consuming than the fully automated evaluation 
standard. However, the great threats that arise from data repurposing (Hersh et al., 2013; 
Van Der Lei, 1991) demand thorough evaluations that are often not detectable using 
automated data checks. Finally, DataGauge only focuses on assessing defined by the 
DNM and data contained in the analytical dataset rather than all potentially relevant data 
in the CDW.  Nevertheless, there are currently no other ways of defining analysis-
specific data needs and quality requirements in a consistent way, which makes 
DataGauge a valuable tool for the clinical research informatics community. 
The guidance framework to support DataGauge presents four main limitations. First, it 
may not include all relevant dimensions. Generating all relevant DQ requirements 
depends on many aspects of the data, their intended use and their meaning, yet the 
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dimensions included are the ones found to be most significant from our research 
experience. Second, the comprehensive nature of the framework may lead to the 
generation of redundant DQ requirements. Third, the framework, in its current state, may 
tax users with a large number of questions for DQ requirement generation. Therefore, it 
may not be practical for day-to-day DQ assessment projects. Refinement and testing of 
this guidance framework will be done in future work. Finally, though it interfaces with 
other DQ frameworks (Johnson et al., 2015; M. Kahn et al., 2015; M. G. Kahn et al., 
2012) , it may be useful to integrate them in future work as well.  
The evaluation of DataGauge presents four limitations. First, the evaluation was based on 
a single clinical database containing outpatient data. Though this is only one type of 
clinical data it is one of the most broadly available for secondary use and one database is 
a reasonable starting point for an initial evaluation. Second, a limited number of cases 
were used for the development of the guidance framework and evaluation. Still, these 
cases were justified to cover over 90% of secondary uses and clinical data types. Third, 
only two experts were interviewed to develop the DQ requirements that served as the 
basis to develop the guidance framework the evaluation. This is acceptable because the 
method is still in its early stages of development and this evaluation was preliminary in 
nature. Finally, the ideal comparison standard for the evaluation of DataGauge would 
have been a naive research team using their habitual cleaning methods. However, this 
option was impractical in our current setting for three reasons: (1) finding research teams 
willing to adopt a new, untested technique can be challenging, (2) including a human 
element in the evaluation process would introduce much variability in the results and 
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would, therefore, require a much larger sample size and (3) the funding needed to run 
such study was not currently available. DataGauge is in its early stages of its 
development and, thus, a proof of concept evaluation against the current state of the art 
tools is prudent and will inform future research. Thus, we chose to use a standardized 
baseline method that would minimize the involvement of humans and maximize the 
feasibility and repeatability of the evaluation.  
6.2 - Contributions  
DataGauge contributes to the current state of the science in three ways. First, it advances 
applications by supporting more through checks of repurposed clinical data and enabling 
their systematic yet purpose-specific DQ assessment. Such checks are necessary because 
repurposed clinical data may not be appropriate for their intended secondary purpose 
(Van Der Lei, 1991). This work lays the practical foundation for the systematic DQ 
assessment of repurposed clinical data as an evaluation of fitness for purpose (Holve et 
al., 2013). This contributes to support the reliable secondary use of clinical data (Charles 
Safran et al., 2007), which is a critical step towards building learning healthcare systems 
(Institute of Medicine (US) Roundtable on Evidence-Based Medicine, 2007). Second, 
DataGauge has been shown to improve upon the current state-of-the-art systematic DQ 
assessment method by providing a systematic yet purpose-specific approach.  This new 
assessment methodology flags more potential issues than an alternative automated 
approach. It also improves current methods and practices by promoting the explicit 
definition of DQ assessment requirements (M. Kahn et al., 2015; M. G. Kahn et al., 2012) 
and data extraction parameters. These explicit definitions also show promise in enabling 
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a smoother data extraction process through the definition of explicit requirements. In our 
experience, data extraction is the source of much inefficiency and 'back and forth' 
between the analytics teams and database administrators this is partly due to the 
ambiguity of requests, usually submitted as plain text descriptions. Providing a standard 
for the explicit definition of data extraction requirements, such as the DNM, can 
eliminate much inefficiency by improving communication. The explicit definition of DQ 
requirements is also a contribution to current practices given that transparent reporting of 
DQ results is a current route of development in the field (M. Kahn et al., 2015), yet no 
applied methodological support to such practices is found in the literature. Also, explicit 
DQ requirements have the potential to set the groundwork for automated DQ assessment 
in the future.  Lastly, my work contributes to the field of biomedical informatics by 
providing a preliminary inventory of concerns and potential issues to be checked while 
making secondary use of clinical data. The guidance framework provides a list of 
knowledge domains that ensure all expertise needed for the secondary use of data is 
accounted for. The guidance framework and, more specifically, the overview checklist 
supports the separation of concerns (Painter, 2006) in DQ requirement generation tasks. 
The principle of separation of concerns is responsible the orderly and modular design of 
current computer programs. I anticipate that this framework and overview based on this 
principle will be a first step towards an orderly and modular generation of DQ 
requirements. This is particularly important because of the complexity involved in the 
generation of DQ requirements, which stems from the multiple sources of information to 
be taken into account for a specific dataset and research question. This guidance also 
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promotes a team-based (Barlow, 2013) definition of requirements that is desirable, yet 
poorly supported by current practices (Broeck & Fadnes, 2013).  
6.3 - Future Work 
Future work will consist of further testing and development of the DataGauge and the 
guidance framework. DataGauge will be tested with analytics teams making secondary 
use of clinical data. An evaluation where a control group uses their native methods to 
clean their datasets and an experimental group applies the DataGauge procedure will be 
carried out. The DQ results for each group will be compared.  Also, I will further expand 
the guidance framework by exploring more secondary use cases. Finally, the DataGauge 
process will be iteratively improved and streamlined based on end-user feedback. 
Because DataGauge is intentionally designed to require considerable human input, I plan 
to develop and evaluate tools to support analytical teams as they work through the 
process, much as software engineers and programmers now use a number of different 
tools to capture requirements, track changes, and track issues. 
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Appendix A: Definitions 
Data: "A datum is a putative fact regarding some difference or lack of uniformity within 
some context." (The Philosophy of Information, 2013) In other words, data are discrete, 
atomic answers to specific questions about an object of interest.  
 
Clinical Data: Discrete, atomic answers to specific questions about a patient's health 
status and healthcare procedures. In this dissertation, I refer to clinical data as all data 
recorded in an electronic health record. 
 
Quality: "The totality of features and characteristics of a product or service that bear on 
its ability to satisfy stated or implied needs" (Standardization, 1994) 
 
Data Quality: A dataset's ability of satisfying the needs for a specific purpose (Holve et 
al., 2013) (i.e., fitness for purpose (Juran, 1962)) 
 
Purpose:  "Something set up as an object or end to be attained" (The Merriam-Webster 
Dictionary, n.d.). We refer to purpose in this dissertation as the use of data to answer a 
specific research question. 
 
Initial purpose: The purpose for which the data are first produced; also known as the 
production purpose (Floridi, 2012, 2013). 
 
Data Repurposing: Using data for any purpose other than for which they were 
produced(de Lusignan & Mimnagh, 2006; Van Der Lei, 1991). 
 
Secondary Purpose or Secondary use: Any use of data other than the use for which 
they were collected; also known as the analytical or secondary purpose(Botsis, 
Hartvigsen, Chen, & Weng, 2010; Floridi, 2012, 2013; C. Safran, 2014). 
 
Criterion: "A standard on which a judgment or decision may be based or a 
characterizing mark or trait" (The Merriam-Webster Dictionary, n.d.). For this 
dissertation, I define a criterion is a axis of interest upon which a value of adequacy can 
be assigned, an evaluation can be carried out or a decision can be made. 
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DQ criterion: A point of interest upon which a dataset's fitness for a specific use can be 
evaluated. The evaluation will provide a degree of adequacy for the use in relation to a 
specific criterion. Each criterion defines a sub-feature of the overall fitness for purpose.  
 
DQ requirement: A condition describing a specific feature that must be respected by a 
dataset in order to be fit for a specific use or purpose. Each requirement defines a specific 
sub-feature of the overall fitness for purpose. Requirements describe the desirable aspect 
for a dataset in the light of a criterion, which is defined by the intended use. DQ 
requirements define the minimum expectation on data values to ensure that a specific 
dataset is valid and useful for a specific analytical purpose. They aim to define a "fit-for-
purpose" dataset in a specific case.  
 
DQ Standard: In this dissertation, I refer to DQ standard as the combination of all DQ 
requirements for a specific dataset and intended use. DQ standards are not 
interchangeable and must be generated in the light of domain knowledge, the available 
data and the intended purpose or research task. 
 
Inclusion/Exclusion Criteria: We differentiate DQ requirements from 
Inclusion/Exclusion criteria by the object they define and their goal. Inclusion/Exclusion 
criteria define the subjects that qualify for the study based on demographic and clinical 
considerations; they aim to define a patient population. For example, "patient is at least 
18 years old" is an inclusion criterion whereas "patient date of birth is earlier than 
observation date" is a DQ requirement. 
 
DQ rule: "Data quality rules are constraints that validate data relationships and can be 
checked using computer programs" (Maydanchik, 2007a). In this dissertation I refer to 
DQ rules as an explicit, unambiguous limits that are easily encoded into machine-
executable code to automatically flag infringing data within the assessed datasets. We 
differentiate them from DQ requirements by their unambiguous and formal (Morton, 
1999) nature.  
 
DQ test: A practical tool, algorithm, approach or strategy employed to test the adherence 
of a dataset to a specific DQ requirement or the breach of a DQ rule. They serve as a 
means to gather evidence of a dataset's fitness for purpose for a specific DQ criterion.  
 
DQ Assessment: A judiciously selected combination of DQ tests based on DQ 
requirements to assess a dataset's fitness for a specific analytical purpose based on 
clinical, data science and analytical tool knowledge.  
DQ assessments vs. DQ tests: A DQ assessment is a combination of DQ tests designed to 
evaluate whether a dataset is fit for a specific purpose. DQ requirements and DQ rules 
define the parameters necessary to run the DQ tests.  
 
Data Needs Model:  An explicit, unambiguous external representation of the minimal 
data needed to achieve a specific research task or goal. In this dissertation, data needs 
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model refers to a tidy-data-compliant (Wickham, 2014) UML model (Demuth & 
Hussmann, 1999) of the minimal clinical data required to answer a specific research 
question.  
 
Research Question Analysis: To define all objects of interest in light of a specific 
research question. In this dissertation, I refer to research question analysis as the steps 
taken to determine the clinical objects (e.g., patients, prescriptions, labs, etc.), which must 
necessarily be known to answer the research questions. From these objects are derived 
the variables that are likely to contain the necessary information to answer the research 
question via secondary analysis. For example, if our research question is "Is Prednisone 
exposure related to weight gain?" we will need information about the patients, their 
prednisone prescription history and their weight measurement values. Within these three 
objects we will then define the variables to describe then. For example, a patient may be 
described by a patient identifier, a date of birth and a gender variable. 
 
Data extraction:  Selection of all data that may be relevant to a specific research 
question that is transformed to fit a specific data needs model and subsequently used for 
DQ evaluation and analysis.  
 
DQ evaluation: The implementation of all DQ tests (based on the DQ standard) into 
machine-executable code to detect violations of the predefined DQ requirements. Their 
goal is to provide evidence to support the analytics team's decision on the dataset's fitness 
for purpose. Each DQ evaluation is specific to a research question, a data needs model, a 
DQ standard and an extracted dataset.   
 
DQ results: They are the quantitative evidence of infringement of DQ requirements 
within a given dataset for a specific purpose. They usually take the form of counts, 
percentages or true/false flags and serve to support the expert's decision about a dataset 
being fit or unfit for a specific purpose. They can be assimilated to DQ measures as 
described by Johnson et al. (Johnson et al., 2015). In this dissertation, I represented all 
DQ results as infringement counts or flag counts. 
 
Separation of concerns: "The ability to identify, encapsulate and manipulate only those 
parts of software that are relevant to a particular concept, goal, or purpose” (Ossher & 
Tarr, 2001). In other words, it is the ability of teasing out the different pieces of the 
puzzle interacting in a task. In the task of generating DQ requirement, multiple sources of 
information are at play as well as multiple sources of knowledge (i.e., domain experts). In 
this case, the separation of concerns is the definition of an information structure or 
framework that delineates the role and interactions of each information and knowledge 
source. The guidance framework described in Chapter 4 provides such structure.  
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Appendix B: DQ Requirement Development Guidance  
In this Appendix I present the details of the guidance framework introduced in Chapter 4. 
The framework is composed of two parts: (1) the Data-Knowledge checklist and (2) the 
guidance questionnaires. The Data-Knowledge checklist serves as an overview of all 
possible contexts (i.e., the combination of a clinical data type and a knowledge domain) 
that must be assessed to ensure a thorough DQ assessment design. For each DQ 
requirement generation context (i.e., the combination of a knowledge domain and a 
clinical data type instance), the framework assigns a guidance questionnaire that presents 
all relevant concerns in the form of questions to assess DQ dimension. Each question is 
used as a focus to generate DQ requirements around that specific point of interest taking 
as inputs a specific Data Needs Model piece at a specific data granularity level (e.g., a 
value, an observation, a variable, etc.) and a specific Research Question. The DQ 
requirements should aim to define the ideal dataset for the Research Question or 
Research Goal. Once the analytics team has addressed all pertinent questionnaires and the 
checklist is full, it can be assumed that there is reasonable coverage of potential DQ 
issues in repurposed clinical data.  
 
Data-Knowledge Requirements Development Checklist 
The Data-Knowledge checklist serves as an overview of the different contexts to be 
covered for a thorough DQ assessment design (see table below). Two dimensions define 
it: (1) the Clinical Data Types, which are sub-sections of the electronic medical record 
and (2) the Knowledge Domain, which represent the different types of knowledge 
necessary to carry out a secondary analysis of clinical data.  Thus, we can refer to 
contexts as the combination of specific elements from these to dimensions. For example, 
Appointment data type and Analytical Tool would be the first context in the table below. 
Addressing all combinations between all elements between these two dimensions ensure 
systematicity through thorough coverage of all relevant issues. It is recommended that 
research teams work in groups with all experts present in the room. The Research 
Question and the Data Needs Model should be visible to all and consulted as part of the 
process. It is suggested that the team work their way through the checklist by breaking 
the Data Needs Model down for a Clinical Data Type at all relevant Data Granularity 
Levels, then running thought the questionnaires each knowledge domain and finally 
move on to the next Clinical Data Type. This will facilitate cross-domain thought and 
dialog between the experts, while keeping the evaluated target (i.e., the DNM pieces) 
stable during DQ requirement generation. 
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	 	Clinical	Data	
Types:	
Appointmen
t	
Demographic
s	
Diagnose
s	
Lab
s	
Med
s	
Vital
s	
Kn
ow
le
dg
e	
Do
m
ai
n	
Analytical	Tool	 þ	 ☐	 ☐	 ☐	 ☐	 ☐	
Clinical	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Data	
Manipulation	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Representation	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Research	Design	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Research	Goal	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
Workflow	 ☐	 ☐	 ☐	 ☐	 ☐	 ☐	
 
Question-Driven DQ Requirement Definition 
The guidance questionnaires correspond to specific contexts; that is, a specific 
combination of Knowledge Domain and Clinical Data Type (e.g., Analytical Tool and 
Appointment). For each context, the analytics team will identify the relevant subset of the 
Data Needs Model and break them down in as many possible pieces for every Data 
Granularity Level (i.e., value, variable, observation, observational unit, multiple 
observational units and dataset). They will then address each question for a specific DNM 
piece in the frame of a specific Knowledge Domain. These features are the DQ 
requirements.  Once the team has answered every question, they may move on to the next 
context and answer its questionnaire. It is important that the team keep in mind the 
research question throughout this work in order to generate requirements that define a fit 
for purpose dataset. A full example of the use of this guidance is described in section 4.4. 
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Contextual Questionnaires In Alphabetical Order 
1. Appointment 
1.1. Analytical Tool 
DQ 
Dimension 
Question 
Tool 
Limitations 
Are all statistical assumptions met by the data? 
Tool 
Limitations 
Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest to run 
the analysis? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest to run the analysis? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is the censorship rate acceptable? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there gaps in recording within the timeframe of interest? 
Correctness Are there duplicate observations? 
Completeness Are there enough data points by appointments? 
Completeness Are there enough data points by patient and/or care provider? 
 
1.2. Clinical 
DQ Dimension Guidance Question 
Plausibility Is the appointment date within a plausible timeframe? 
Timeliness Is the time between appointments in the expected range? 
 
1.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
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1.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
 
1.5. Research Design 
DQ Dimension Guidance Question 
Completeness Are any of variables needed for the analysis missing? 
Completeness Are there missing values? 
Completeness Are there values missing not at random? 
Completeness Are there enough values within the desired time range? 
Completeness Is the analytical observational unit (i.e., the main outcome 
variable, dependent variable and covariates in one table line) 
complete?  
Completeness Is the censorship level for each variable of the observational 
unit acceptable? 
Correctness Does the observational unit follow the ideal timeline of 
collection? (e.g., vitals are recorded on visit days) 
Completeness Is the rate of censorship acceptable? Are there enough 
encounters per patient for the designated research design? 
Completeness Are the missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to 
population estimates at large? (i.e., is the sampling random?) 
Completeness Are the data accessible for analysis? (e.g., are the data not 
locked in the clinical notes) 
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# 
available data)? 
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1.6. Research Goal 
DQ Dimension Guidance Question 
Completeness Are the appointment records complete? 
Plausibility Is the age of patient plausible at the appointment time? 
Correctness Does the appointment record map to a single patient? 
Correctness Is there at least one appointment per patient? 
 
1.7. Workflow 
DQ Dimension Guidance Question 
Concordance Are all providers found and defined in the providers table? 
Concordance Are all locations found and defined in the care sites table? 
Concordance Are all provider occupations as expected? (e.g., no medical 
assistants prescribing drugs) 
Correctness Are time stamps in the expected order? (e.g., order before 
admin). 
Timeliness Are time stamps within the expected time frame? (e.g., BPs 
measured within the encounter window vs. outside) 
Correctness Is the time between events of the expected range? 
 
2. Demographics 
2.1. Analytical Tool 
DQ Dimension Guidance Question 
Tool Limitations Are all statistical assumptions met by the data? 
Tool Limitations Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is censorship at an acceptable rate? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there gaps in recording within the timeframe of interest? 
Concordance Are there duplicate observations? 
Completeness Are there enough data points by encounter? 
Completeness Are there enough data points by patient and/or care provider? 
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2.2. Clinical 
 
DQ Dimension Guidance Question 
Correctness Is gender Male, Female or Unknown? 
Completeness Does race contain all expected values? In the 
expected proportions? 
Correctness Are ages within inclusion criteria, non-negative 
and below 130? 
Plausibility Are all dates of birth later than Jan 1st 1900? 
 
 
2.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
 
2.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
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2.5. Research Design 
DQ Dimension Guidance Question 
Completeness Are there missing variables? 
Completeness Are there missing values? 
Completeness Are the values missing not at random? 
Completeness Are there enough values within the desired time range? 
Completeness Is the observational unit defined for the analysis complete? (i.e., are all 
necessary variables present)  
Completeness Is the censorship level for the analytical unit observational unit 
acceptable? (i.e., are there enough values for the analysis overall) 
Correctness Does the observational unit follow the ideal timeline of collection? 
Completeness Are the missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to population estimates 
at large? (i.e., is the sampling random?) 
Completeness Are the data accessible for analysis? (e.g., the data are not locked in 
clinical notes) 
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# available 
data)? 
 
2.6. Research Goal 
DQ Dimension Guidance Question 
Completeness Are the demographics records complete? (e.g., patients have gender, date 
of birth and race values) 
Completeness Does the demographic data have null values? 
Plausibility Is the age of the patient plausible? (e.g., not over 150 years and not 
negative) 
Correctness Do values map to a single patient? 
Concordance Are the patient demographics coherent with issue of interest? (e.g., no 
pregnant males) 
 
2.7. Workflow 
DQ Dimension Guidance Question 
Completeness Are the demographics records entered within the expected observation 
timeframe? (e.g., data entered during a visit) 
Completeness Are there missing values in the demographics data of interest? 
Plausibility Is the age of the patient plausible? 
Completeness Does the patient have the minimum data available to fully describe each 
visit? (e.g., weight and BP must be taken for every visit as good practice) 
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3. Diagnoses 
3.1. Analytical Tool 
DQ Dimension Guidance Question 
Tool 
Limitations 
Are all statistical assumptions met by the data? 
Tool 
Limitations 
Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is censorship at an acceptable rate? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there recording gaps within the timeframe of interest? 
Correctness Are there duplicate observations? 
Completeness Are there enough data points by encounter? 
Completeness Are there enough data points by patient and/or care provider? 
 
3.2. Clinical 
DQ Dimension Guidance Question 
Completeness Diagnoses of interest appear at least once? 
Plausibility Are all diagnoses recorded after the patient's date of birth? 
Timeliness Are the diagnoses recorded during a visit that falls within the expected 
observation timeframe or before the first visit (i.e., medical history)? 
Completeness Are diagnoses recorded at regular intervals in the timeframe of 
interest? 
 
3.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
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3.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
 
3.5. Research Design 
DQ Dimension Guidance Question 
Completeness Are there missing variables? 
Completeness Are there missing values? 
Completeness Are the values missing not at random? 
Completeness Are there enough values within the timeframe of interest? 
Completeness Is the analytical observational unit complete?  
Completeness Is the censorship level for the analytical observational unit acceptable? 
Correctness Does the observational unit follow the ideal timeline of collection? 
Plausibility Is the censorship rate acceptable? 
Correctness Are missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to population estimates 
at large (i.e., is the sampling random)? 
Completeness Are the data accessible for analysis? (i.e., are the data not locked in 
clinical notes?) 
 
3.6. Research Goal 
DQ Dimension Guidance Question 
Concordance Are there diagnoses that conflict or interact with the 
phenomenon in questions? 
Timeliness Are there comorbidities at the time of the visit of interest?  
Completeness Are the diagnoses of interest present?  
Concordance Do the diagnoses evolve as expected?  
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# 
available data)? 
 
 
 
 
 
  
 
132 
3.7. Workflow 
DQ Dimension Guidance Question 
Timeliness Are there conflicting diagnoses overlapping in time? 
Concordance Are there duplicate diagnoses? 
Plausibility Are all diagnoses recorded after patient's data of birth? 
Correctness Are the diagnoses within the expected observational 
timeframe? 
Completeness Are there diagnoses of interest within the desired timeframe? 
 
4. Labs 
4.1. Analytical Tool 
DQ Dimension Guidance Question 
Tool 
Limitations 
Are all statistical assumptions met by the data? 
Tool 
Limitations 
Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is censorship at an acceptable rate? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there recording gaps within the timeframe of interest? 
Correctness Are there duplicate observations? 
Completeness Are there enough data points by encounter? 
Completeness Are there enough data points by patient and/or care provider? 
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4.2. Clinical 
DQ Dimension Guidance Question 
Completeness Are all expected lab values present? 
Completeness Are there any missing values for each lab record? (e.g., value 
with timestamp) 
Completeness Do matching values have a match? (e.g., lipid panel) 
Completeness Is the distribution of values distribution as expected? 
Completeness 
 
Are the values within limits for the population? 
Completeness Are there enough measurements within the expected observation 
window? 
Plausibility Are the labs dated after the patient's date of birth? 
Completeness Are there sufficient values over time for the analysis? 
Correctness Is the frequency of lab values as expected? 
Plausibility Is the difference in consecutive measurements in an encounter 
within acceptable range? 
Plausibility Is the difference in consecutive measurements within an 
acceptable range of than the average difference for the 
individual? 
Plausibility Is the difference between variable values between two time 
points in acceptable proportion? 
Plausibility Are there any sudden changes over time? Are they valid? 
Concordance Are the values coherent or vary as expected within a visit? 
Concordance Is the overall vital measure variability as expected? 
Concordance Are there statistical outliers? 
Completeness Are there timestamps at regular intervals within expected 
observation timeframe? 
Completeness Lab results contain positive, negative and numeric values? 
Correctness Is the temporal frequency of labs as expected for a patient?  
Completness Is the temporal density as expected for the population?  
 
4.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
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beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
 
4.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
 
4.5. Research Design 
DQ Dimension Guidance Question 
Completeness Are there missing variables? 
Completeness Are there missing values? 
Completeness Are the values missing not at random? 
Completeness Are there enough values within the timeframe of interest? 
Completeness Is the analytical observational unit complete?  
Completeness Is the censorship level for the observational unit acceptable? 
Correctness Does the observational unit follow the ideal timeline of collection? 
Correctness Are missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to population estimates 
at large? (Is the sampling random? 
Completeness Are the data accessible for analysis? (e.g., are the data not locked in 
clinical notes?) 
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# available 
data)? 
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4.6. Research Goal 
DQ Dimension Guidance Question 
Completeness Are the lab results complete and with adequately recorded 
values? 
Completeness Does the lab result contain all expected values? 
Correctness Are the lab values in the expected format and unit? 
Completeness Does the data have null values? 
Correctness Is the age of patients plausible at the time of the lab? 
Correctness Do labs correspond to a single patient? 
Timeliness Are there enough values within the desired timeframe? 
Completeness Does the patient have enough data once non-compliant 
values have been eliminated? 
Concordance Are there sudden changes in values over time? 
Concordance Are the values of interest coherent with the patient's history? 
Is it a potential outlier? 
 
4.7. Workflow 
DQ Dimension Guidance Question 
Concordance Are there overlapping labs? Do they present disparate values? 
Concordance Are there duplicate labs? 
Plausibility Are the labs recorded after patient's date of birth? 
Completeness Are there enough labs within the desired timeframe? 
 
5. Meds 
5.1. Analytical Tool 
DQ Dimensions Guidance Question 
Tool Limitations Are all statistical assumptions met by the data? 
Tool Limitations Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is censorship at an acceptable rate? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there gaps in recording within the timeframe of interest? 
Correctness Are there duplicate observations? 
Completeness Are there enough data points by encounter? 
Completeness Are there enough data points by patient and/or care provider? 
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5.2. Clinical 
DQ Dimension Guidance Question 
Completeness Does the dataset contain prescriptions of the drug of interest? 
Completeness Are numeric values within the expected range? 
Completeness Is the sig complete for all prescriptions? 
Concordance Are there overlaps between prescriptions?  
Concordance Are there multiple prescriptions of the same drug at the same 
time? 
Completeness Is a drug exposure variable calculable from the available data 
for every prescription? 
Correctness Is the dose of medications prescribed in multiples of the 
commercially available strength? 
Correctness Is the daily dose within an acceptable range? 
Plausibility Is the number of refills within an acceptable range? 
Plausibility Does the total quantity dispensed match the duration and 
dose prescribed? 
Correctness Is the total quantity dispensed within an acceptable dose 
range for the medication? 
Correctness Is the number of days prescribed within an acceptable range? 
Correctness  Is days>0 and <200? 
Correctness  Are all strength values>0 and <[max commercial strength]? 
Correctness  Are doses>0 and <2*[max daily dose]? 
Correctness  Are refills>=0 and <10? 
Plausibility Is total quality=days*dose? 
Plausibility Is total quantity>0 and <600? 
 
5.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
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5.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
 
5.5. Research Design 
DQ Dimension Guidance Question 
Completeness Are there missing variables? 
Completeness Are there missing values? 
Completeness Are the values missing not at random? 
Completeness Are there enough values within the timeframe of interest? 
Completeness Is the analytical observational unit complete?  
Completeness Is the censorship level for the observational unit acceptable? 
Correctness Does the observational unit follow the ideal timeline of collection? 
Plausibility Is the censorship rate acceptable? 
Correctness Are the missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to population estimates 
at large? (i.e., is the sampling random) 
Completeness Are the data accessible for analysis? (e.g., are the data locked in the 
notes)? 
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# available 
data)? 
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5.6. Research Goal 
DQ Dimensions Guidance Question 
Completeness Does the prescription contain the medication of interest? 
Correctness Does the prescription correspond to a patient? 
Concordance Are there medications that interact with the drug of interest? 
Concordance Are there simultaneous prescriptions? Of the same drug?  
Concordance Are there overlapping prescriptions? 
Concordance Are there prescriptions that interact with the phenomenon of 
interest? 
Completeness Is it possible to calculate an effective dose? 
Concordance Are the prescriptions renewed? Stopped? 
Concordance Are the prescriptions coherent with the diagnoses? 
Completeness Are there diagnoses, vitals or other clinical data available at the time 
of prescription? 
Completeness Is the sig complete? 
Timeliness Are there enough patients with prescriptions in the timeframe of 
interest? 
 
5.7. Workflow 
DQ Dimension  Guidance Question 
Concordance Are there overlapping prescriptions? 
Completeness Are the prescriptions renewed? 
Plausibility Are the prescriptions recorded after patient's date of birth? 
Timeliness Are the prescriptions within the expected observational time? 
Completeness Are there prescriptions within the desired timeframe? 
Concordance Are the prescriptions  recorded during a visit or encounter? 
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6. Vitals 
6.1. Analytical Tool 
DQ 
Dimension 
Guidance Question 
Tool 
Limitations 
Are all statistical assumptions met by the data? 
Tool 
Limitations 
Can you assume independence between observations? 
Completeness Are there enough observations within the timeframe of interest? 
Completeness Are there enough patients with all relevant variables within the 
timeframe of interest? 
Completeness Are there enough observations to provide appropriate statistical power? 
Completeness Is censorship at an acceptable rate? 
Completeness Are the measurements recorded at reasonably regular intervals? 
Completeness Are there gaps in recording within the timeframe of interest? 
Correctness Are there duplicate observations? 
Completeness Are there enough data points by encounter? 
Completeness Are there enough data points by patient and/or care provider? 
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6.2. Clinical 
 
DQ Dimension  Guidance Question  
Completeness/ 
Correctness 
Is the numeric distribution of values and value frequencies as 
expected?  
Completeness/ 
Correctness 
Is the number of vital measurements as expected? (e.g., at least 
one weight measurement per visit)   
Completeness/ 
Correctness Do related values have a match? (e.g., systolic + Diastolic)   
Completeness/ 
Correctness Are there any missing values for each vital record?   
Completeness/ 
Correctness 
Are there an adequate number of measurements within the 
desired observation window?  
Concordance Is the overall vital measure variability as expected? 
Concordance Are there any sudden changes over time? Are they valid? 
Concordance Are the values coherent or vary as expected within a visit? 
Correctness Is the difference in consecutive values in an encounter within acceptable range? 
Correctness Is the difference between variable values between two time points in acceptable proportion?  	
Correctness Are the measurements taken after the patient's date of birth? 
Correctness Are all values within plausible limits for the population? 
Completeness Is the time between events of the expected range? 
Correctness Are time stamps within the expected time frame (e.g., BPs measured within the encounter window vs. outside). 
Timeliness Are time stamps in the expected order? (e.g., order before admin). 
Timeliness Are there sufficient values over time for the analysis? 
 
 
6.3. Data Manipulation 
This Knowledge Domain is beyond DQ dimensions and requirements. Good data 
management practices should prevent any DQ issues in this context, yet it is 
recommended to verify that no issues arose from extraction. At this stage, the data 
scientist designs tests and fail-safes to avoid corrupting the dataset during the data 
manipulations and extract-transform-load (ETL) procedures and/or identify them once 
the data has been extracted. One example such issues is the creation of duplicates when 
using joins. To avoid such issues, the data base administrator should verify the counts 
after every join to ensure no duplication has taken place. These checks are usually done 
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary 
beyond the tests defined by the data scientist but could still be defined for thoroughness 
purposes.  
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6.4. Representation 
DQ Dimension Guidance Question 
Representation Are all Primary Keys unique? 
Representation Do all foreign keys correspond to one primary key? 
Representation Are all values formatted appropriately or as expected? 
Representation Are all values of the right sort (e.g., character, numeric, etc.)? 
Representation Are all predefined values (i.e., concepts) found in the 
dictionary? (e.g., ICD-9) 
Representation Are all defined concepts of interest found in the dataset? (e.g., 
if the concept 'male' is defined to be used in the gender variable, 
the variable should contain 'male' values) 
 
6.5. Research Design 
DQ Dimensions Guidance Question 
Completeness Are there missing variables? 
Completeness Are there missing values? 
Completeness Are the values missing not at random? 
Completeness Are there enough values within the desired time range? 
Completeness Is the observational unit defined for the analysis complete?  
Completeness Is the censorship level for the observational unit acceptable? 
Correctness Does the observational unit follow the ideal collection timeline? 
Completeness Is the ratio of censorship acceptable (i.e., # missing data/# available 
data)? 
Completeness Are the missing values spread randomly over time? 
Correctness Does the distribution of demographics correspond to population estimates 
at large? (i.e., is the sampling random?) 
Completeness Are the data accessible for analysis? (e.g., is the data locked in clinical 
notes) 
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6.6. Research Goal 
DQ Dimensions Guidance Question 
Completeness Are the vital records complete? 
Completeness Does each observation contain all specific measurements required 
for analysis? 
Completeness Does the data set have null values for ideal analytical observation 
unit? 
Plausibility Is the age of patient plausible at the time of measurement? 
Correctness Do vital observations map to a single patient? 
Timeliness Are there enough values within the desired timeframe? 
Completeness Does the patient have enough data once the record is cleaned? 
Concordance Are there sudden changes in values over time? 
Concordance Is the value of interest coherent with the patient's history? Is it a 
potential outlier? 
 
 
6.7. Workflow 
 
DQ Dimension Guidance Question 
Completeness Are there vitals for every observation year? 
Plausibility Are all measures after the patient's date of birth? 
Correctness Are the measures within the expected observation range? 
Plausibility Are all expected vital measures within each encounter? (e.g., routinely recorded values such as weight, BP, etc.) 
Concordance Is the provider the same for all measures within the encounter? 
Concordance Are all readings for the same visit entered within an hour of each other for outpatient data? 
Completeness Is the measurement rate as expected for repeated measures? 
Concordance Do matched measurements have the same caregiver? (e.g., systolic and diastolic) 
Correctness Do patients have more measurements than expected? 
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Appendix C: Use Case Definitions 
Case 1- Duplicate BP measurements  
Goal: Use of a CDW to assess whether there is a difference between blood pressure (BP) 
measurements when a repeated measures protocol is in place.  
 
Research Question: Is the second BP measure statistically lower than the first BP 
measure taken within a visit? 
 
Hypothesis: Subsequent BP measurements (second, third, etc.) are lower than the first BP 
measurement taken during that visit. 
  
Possible Analyses:  
Linear Regression model- Predict 2nd BP value based on 1 BP value (used for validation) 
Linear Regression model 2- Outcome Variable = Difference between BP measurements 
GEE or mixed effect model (repeated measures)- for multiple data points  
 
Final Data Needs Model: 
 
 
 
  
 
144 
Case 2- Caregiver relationship to BP measurements 
Goal: Describe the number of blood pressure recordings by caregivers along visit units to 
assess the relationship, if any, between the caregiver and the implementation of the 
double measurement blood pressure protocol. 
 
Research Question: Are dual BP measurements provider-dependent? 
 
Hypothesis: There is a relationship between the number of BP measurements recorded 
and the caregiver's background, training and occupation.  
 
Analysis:  
Logistic GEE or mixed model - Accounts for patient-level correlation and covariates. 
Main outcome variable= 2 BP measurements per visit? Binary Variable (yes/no)   
 
Final Data Needs Model:  
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Case 3- Observational study of weight trends in population  
Goal: Identify and describe the types trends in the weight changes of patients from the 
point of view of an outpatient clinic.  
 
Research Question: What are the modes of variation of weight values over time? 
 
Hypothesis: There are district patterns of weight evolution over time that depend on the 
patient's demographic and health information. 
 
Possible Analyses:  
Sparkline, trend line and line plot visualization techniques. 
Linear regression for adjusted mean weight. 
 
Final Data Needs Model: 
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Case 4- Relationship between drug intake and side effect  
Goal: Identify the relationship between prednisone and weight gain in clinical care data.  
Research Question: 4. Is prednisone exposure correlated with weight gain? 
Hypothesis: There is a positive relationship between prednisone exposure and weight 
change over time.   
Possible Analysis:  
GEE regression model predicting weight change over time after first prescription based 
on prednisone exposure levels.   
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Case 5-Relationship between BMI and HbA1c lab values  
Goal: Identify and describe the relationship between BMI and HbA1C and glucose lab 
test results.   
Research Question: Are HbA1C lab values correlated with BMI? 
Hypothesis: Patients with higher BMI have higher glucose and HbA1C readings  
Analysis:  
Linear Regression predicting HbA1c values based on BMI values 
Final Data Needs Model: 
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Case 6-Recruiting patients with BMI>25 and age>21 
Goal: Identify patients with the following characteristics: BMI>25 and age>21 
 
Research Question: Can we find patients BMI>25 and age>21? 
 
Hypothesis: N.A.   
 
Analysis: N.A.   
 
Final Data Needs Model: 
 
 
